In vivo studies of mitochondrial tRNA mutations in S. cerevisiae by De Luca, Cristina
IN VIVO STUDIES OF MITOCHONDRIAL tRNA MUTATIONS IN  
S. CEREVISIAE  
 
 
 
CRISTINA DE LUCA 
 
 
 
DOTTORATO IN BIOLOGIA CELLULARE E DELLO SVILUPPO  
XVII ciclo 
DIP. BIOLOGIA CELLULARE E DELLO SVILUPPO, UNIVERSITÀ DI ROMA  
“LA SAPIENZA” 
 
 
 
Docente Guida: Dott.ssa Silvia Francisci* 
Tutore: Prof. Claudio Palleschi* 
Coordinatore della scuola di dottorato: Prof.ssa Laura Frontali* 
Docenti esaminatori: Prof. Rodolfo Negri*  
                                     Prof.ssa Paola Paggi*  
                                     Prof.ssa Patrizia Lavia^ 
*Dip. Di Biologia Cellulare e dello Sviluppo, Univ. LA SAPIENZA, ROMA 
^Istituto di Biologia e Patologia Molecolare, CNR, ROMA 
 
 
 
 
 
 
  
Abstract 
Yeast mitochondria were taken as a versatile tool to investigate the pathogenecity and the 
mechanism of mitochondrial dysfunction due to point mutations in tRNA genes correlated in 
humans with neurodegenerative diseases.  
The biolistic mutants LysG38A, equivalent to the G8328A mutation correlated in humans 
with mitochondrial encephalomyopathy, and IleT33A, equivalent to the human position 4290 
of tRNAIle, were constructed and characterized. The analysis of two other yeast mutants in 
the anticodon region revealed that mutations involving the same position even on different 
tRNA genes may cause similar defects. Moreover, the efficiency of the mt-tRNA-synthetases 
as well as the EF-Tu to suppress the defective phenotype was tested. Finally, the importance 
of the nuclear background in which the mitochondrial mutation is expressed was investigated 
by changing the nuclear context of each mutant and quantifying the expression level of the 
TUF1 gene in different wild-type and/or rho° strains. 
The results here described may allow the possibility to investigate the pathogenic potential of 
some tRNA human mutations and to search for nuclear genes that can either suppress or 
modify the defective phenotype.  
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1.1 Saccharomyces cerevisiae  
 
 
Yeasts are unicellular fungi - a large, heterogeneous group of eukaryotic organisms. The 
budding yeast Saccharomyces cerevisiae, phylum Ascomycetes, has been successfully used as 
an experimental system in the investigation of fundamental biological processes e.g. 
transcription, translation, cell cycle, and membrane transport. 
Saccharomyces cerevisiae has a facultative aerobic metabolism. Thanks to its ability to 
ferment glucose to ethanol and carbon-dioxide, it has played a central role in food production 
and conservation over the centuries. 
Yeasts are ideal for genetic studies of eukaryotic cell biology because they duplicate almost as 
rapidly as bacteria and have a genome size less than 1/100th that of a mammal. S. cerevisiae 
genome, totally sequenced in 1997, consists of 12.06 Mbp (Goffeau et al. 1996) of DNA and 
contains about 6,000 genes organized in 16 linear chromosomes.  In this genome 
approximately 140 genes code for ribosomal RNA, 40 genes for small nuclear RNA, and 275 
transfer RNA. 
The average cellular diameter is 5 µm depending on the growth phase or the cell cycle, and 
the cell may appear with a spherical or elliptical shape. S. cerevisiae can proliferate in either 
diploid or haploid state. The diploid cells can divide by mitosis or can go through meiosis to 
form haploid cells. The haploid cells can divide or can conjugate (mate) with another one to 
form diploid cells (Fig. 1). The formation of the diploid nucleus during conjugation requires 
the fusion of two haploid cells followed by the fusion of their nuclei (karyogamy) activated by 
a particular pheromone (Rose et al. 1986).  Yeast cells produce two different pheromones 
depending on the information contained in the MAT locus, a or α. These pheromones have a 
mature form which is able to bind a receptor present on the membrane surface of an opposite 
mating type cell.  
Cell's growth rate varies according to the supply of nutrients and other factors: with normal 
quantities of nutrients present, diploid cells divide by mitosis (cell-cycle time is about 2 
hours); under stressful conditions, diploid cells undergo meiosis producing 4 haploid cells 
(spores) contained in an ascus. Upon returning to favourable conditions, haploid a and α cells 
can germinate and mate to restore the diploid state.   
Genetic and molecular methods such as complementation, meiotic analysis and molecular 
cloning can be used to characterize yeast mutants. During complementation experiments 
mutant strains are crossed with tester and control strains in order to reveal the mutation; the 
analysis of the diploid phenotype is useful to establish whether the mutation is recessive. This 
technique has been used to isolate endogenous as well as heterologous genes, functional 
analogues (orthologues), from higher eukaryotes (Leem et al. 2002, Noskov et al. 2003).    
Meiotic analysis is a method used to determine if the mutation is at a single locus and to 
determine genetic linkage between genes. The isolation and the sporulation of the diploid is 
followed by tetrad analysis; because each tetrad is the product of a single meiotic event it is 
possible to reveal the genetic linkage from the phenotype segregation pattern. 
Functional analysis of S. cerevisiae genome continues to provide growing information about 
the proteins encoded by this genome; the status of this analysis is reported in the graphic in 
Fig. 2. 
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Fig. 1 Saccharomyces cerevisiae life cycle. 
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• 3D - protein sequence has a 3D model built by homology, or a known 3D 
structure.  
• clear_function - protein sequence has functional annotation derived from 
probable     homologues.  
• tentative_function - protein sequence has functional annotation derived 
from tentative homologues.  
• homologue - protein sequence has probable homologues of unknown 
function.  
• no_homologue - protein sequence has no probable homologues.  
 
Fig. 2 Level of information known about S. cerevisiae genome. 
 
S. cerevisiae has a facultative aerobic metabolism i.e. in the absence of oxygen it is able to 
perform the alcoholic fermentation by converting glucose into ethanol. In aerobic condition, 
glucose is converted to energy by the citric acid cycle and the electron-transport chain inside 
the mitochondria. 
The carbon source present in the media can influence the metabolism of S. cerevisiae. In the 
presence of glucose, even in the presence of oxygen, this yeast has a fermentative metabolism 
due to the glucose repression of certain enzymes implicated in the metabolic pathway. In 
media containing glycerol or ethanol, only respiration is possible, which means this organism 
needs functional mitochondria to survive on these carbon sources. 
This interesting aspect of S. cerevisiae metabolism permits the study of mutations which 
cause alterations in the mitochondrial function. 
 
1.2 Mitochondria 
 
1.2.1 The origin of Mitochondria 
 
Discovered by optic microscopy observation in 1850, mitochondrion has always interested 
scientists because of its presence in all the eukaryotes and because the information contained 
in the mitochondrial genome is conserved among different organisms. 
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There are many theories on the origin of mitochondria. The 19th century endosymbiotic theory 
developed by Margulis has been extensively challenged using molecular methods. According 
to this theory, mitochondria originated by an ancient eubacteria endocitosis inside cellular 
lines destined to be eukaryotes (Margulis 1970). Phylogenetic reconstructions seemed to 
confirm this hypothesis even if further sequence analyses and extensive genome comparisons 
significantly modified it (Kurland and Andersson 2000).  
Since 1998 the standard model suggests that the identified endosymbiont is Paracoccus, α-
proteobacterium, and the host is an Archeon  (Doolittle 1999, Gray 1992). This symbiotic 
relationship has been recently analysed from the biochemical point of view and seems 
independent from the sharing of ATP that has been produced. Therefore there are two 
possible models to explain this relationship: one based on an evolutionary path, initially 
supported by anaerobic syntrophy (Lopez-Garcia and Moreira 1999); the other, involving 
aerobic mutualism (Andersson and Kurland 1999), predicts that the aerobic host made 
pyruvate accessible to the aerobic symbiont with respiratory chain.  
 
1.2.2 Biogenesis, structure and function of mitochondria 
 
Mitochondria are cytoplasmic organelles present in all eukaryotic cells; they produce more 
than 95% of ATP through oxidative reactions and they are essential for other metabolic 
pathways involving mitochondrion-localized steps. 
Mitochondria originated from pre-existing organelles and many factors involved in their 
segregation are conserved from yeast to mammals, suggesting that the mechanisms are 
similar. In larger eukaryotic cells segregation is performed by a cooperation between 
microtubules and microfilaments (Bretscher 2003). Yeast has two distinct actin nucleation 
systems: an Arp2/3 dependent one, for cortical patch assembly [needed for endocytosis and 
localized cell wall synthesis (Schott et al. 2002)], and a formin-dependent one for actin cables 
assembly, which is necessary for organelle segregation during cell division (Evangelista et al. 
2002). 
Microscopy studies suggest that mitochondrial structure can appear in two different 
morphological states: during inter-phase stages, mitochondria can be seen as a continuously 
branched reticulum (Fig. 3) of connected tube-like filaments with an approximate tube 
diameter of 0.5 µm (Rizzuto et al. 1998); during cell division they appear as ellipsoid shaped 
vesicles (Perkins et al. 1997). These changes are related to physiological conditions. The 
molecular bases of mitochondrial redistribution must rely on protein conformation changes 
that operate on relatively fast (subsecond) time scales (Knowles et al. 2002). 
 
 
 
 
 
Fig. 3 Yeast mitochondria labelled with matrix localized GFP. 
www.hopkinsmedicine.org/cellbio 
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Opposing fission and fusion events maintain the yeast mitochondrial membrane network; 
such processes are regulated by at least six proteins: Dnp1p, Mdv1p, Fis1p for fission, Fzo1p, 
Mgm1p and Ugo1p for fusion (Gorsich and Shaw 2004). Strains defective for fission or  
fusion show problems during meiosis and sporulation events suggesting that these 
mechanisms are essential to complete these processes. 
Mitochondria are bounded by a double membrane. The outer membrane is permeable to  
small molecules and a large number of ions.  The inner membrane forms cristae (Fig. 4) and 
contains complexes necessary for the oxidative reactions. The electron transport associated 
with the oxidative fosforilation is coupled with a proton gradient across the membrane which 
is used by the membrane ATPase complexes to produce ATP.  
 
 
 
 
 
 
 
 
Fig. 4 Image of mitochondrial cristae. www.academicbrocklyn.cuny.edu 
 
 
In the matrix of mitochondrion other processes take place, e.g. the oxidation of pyruvic acid 
(Kreb cycle) and fat acids.  
Mitochondrial biogenesis requires the expression of about 1,000 genes, which are encoded not 
only by the nuclear genome but also by a mitochondrial DNA present inside the matrix in 
several copies.  
 
1.3 Saccharomyces cerevisiae mitochondrial DNA 
 
Saccharomyces cerevisiae mitochondrial genome is a circular molecule of DNA (Fig. 5). The 
molecule size may vary from 68 to 85.8 Kbp, depending on the presence of intergenic 
sequences and introns that differentiate one strain to another. 
The S. cerevisiae genome contains: three genes for subunits (6, 8 and 9) of the ATPase  
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complexes; three genes for cytochrome c oxidase subunits I, II and III (COI, COII, COIII, 
respectively); one gene for cytochrome b, Cytb; and one gene for a ribosome-  
 
 
 
 
 
 
Fig. 5 Mitochondrial genome of S. cerevisiae. 
 
 
 
associated protein, VAR1. The remaining regions encode for the 21S and 15S ribosomal 
RNAs and for 24 transfer RNAs. The 9S RNA gene (RPM1) specifies the RNA component 
of the ribonuclease P enzyme. 
Some mitochondrial genes have introns, in particular COI, Cytb and 21S contain introns 
which are ORFs. Three ORFs present in the mitochondrial genome seem to have determinate 
functions: ORF1 and ORF2 seem to code for maturase enzymes while ORF3 code for an 
endonuclease subunit involved in the mitochondrial DNA recombination. 
In the S. cerevisiae mitochondrial DNA all the genes are localized on one strand except for 
the tRNAThr1 gene. Mitochondrial DNA (mtDNA) genes are separated by long, non-coding 
A+T rich regions (62% of the entire genome). Almost 200 GC clusters, short stretches (less  
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than 25-30 bp) very rich in G+C, are interspersed in the mitochondrial genome; some of them 
are “hotspot” with high recombination frequency. Rearrangements of mtDNA are often due 
to recombination between GC clusters  which form structures called “hairpin loops” (Foury et 
al. 1998). It has been observed that GC clusters may have a role also in replication (Van 
Dyck et al. 1992) and transcript maturation (Francisci et al. 1987).  
 
1.4 Mitochondrial mutants 
 
Mitochondrial mutants have a peculiar non mendelian segregation and can be of different 
types depending on the kind of DNA damage or on the position where the mutation is located. 
When a total loss of mtDNA occurs, mutants are denominated rho°. These mutants have no 
functional mitochondria. Usually these mutations are associated with nuclear genes involved 
in the mitotic stability of mtDNA or with the presence of cell-cycle and transcription 
alterations (Koltovaya et al. 2003). 
Yeast “petite” mutants have large deletions in their mtDNAs and amplify the remaining 
region of DNA to the wild-type genome size (Faye et al. 1973). These mutations denominated 
rho-, occur spontaneously with a frequency of 1%, that can be increased using drugs such as 
Ethidium Bromide. 
Strains containing point mutations or small deletions in tRNA or rRNA genes are 
denominated syn-, these mutants are usually unable to perform the mitochondrial protein 
synthesis.  
The three mutations, rho°, rho- and syn-, prevent the cell to breathe.  
Mit- are mutants with small deletions or substitutions in genes coding for enzymatic subunits 
of the respiratory chain.    
AntR are mutants capable of growth in the presence of antibiotics or other inhibitors like 
tetracycline or chloramphenicol which usually interfere with mitochondrial functions. 
Pet- are mutants with deletions or substitutions in nuclear genes encoding for mitochondrial 
proteins.  
 
1.5 Nucleus-mitochondria interactions  
 
In yeast, 477 proteins show evidence of mitochondrial localization; among these, 469 are 
nuclear encoded (Prokisch et al. 2004, http://ihg.gsf.de/mitop). Nuclear encoded factors 
include: DNA and RNA polymerases, the majority of the subunits needed for the 
mitochondrial inner membrane complexes, proteins implicated in the maturation of 
mitochondrial transcripts (Valencik and McEwen 1991), and the nuclear gene RPM2, which 
encodes for a subunit of the RNaseP necessary for the tRNA maturation (Kassenbrock et al. 
1995). 
Nuclear encoded proteins are synthesized on the cytoplasmic ribosomes and are imported into 
mitochondria. Typically, the imported proteins contain a target signal in their N-terminal 
presequences; these signals have the potential to form positively charged amphiphilic helices 
and are removed upon import (Endo et al. 2003). Other imported proteins contain targeting 
signals within the mature protein. 
Mitochondrial import is mediated by membrane translocators, complexes of multiple 
membrane-protein subunits (which are able to function as receptors for target signals, as 
channels and as providers of the driving force for traslocation).  
The S. cerevisiae general entry gate for mitochondrial precursor proteins is TOM complex 
(Traslocase of the Outer Membrane)(Fig. 6). This complex is formed by: receptors for 
precursor proteins, pore-forming protein Tom40, and small Tom proteins (Koziak et al. 
2003). The diameter of this import channel during translocation is between 20 and 26 Å, and  
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this diameter may be affected by the presence of a targeting peptide (Schwartz and 
Matouschek 1999).  
TIM23 (Traslocase of the Inner Membrane) and TIM22 are complexes present in the inner 
membrane (Fig. 6)(Endo et al. 2003). The first one mediates the translocation of presequence-
containing proteins; it has an integral membrane protein Tim23 that forms a dimer depending 
on the potential across the inner membrane, and dissociates at the presence of presequences. 
TIM22 is a complex, forming a pore of 16 Å, needed for  the insertion of presequence-less  
 
 
 
 
 
 
 
 
 
 
polytopic membrane proteins like ADP-ATP carriers and some Tim proteins. Import across 
the inner membrane requires membrane potential ∆Ψ and/or ATP.Recent studies described a 
new mechanism of mitochondria to nucleus stress signaling initiated by mtDNA or membrane 
damage and disruption of ∆Ψm (Biswas et al. 2003). This cellular modulation is called 
retrograde regulation, which is an homeostatic or stress response mechanism to adjust 
metabolic and biosynthetic activities to the alterations in the mitochondrial state (Sekito et al. 
2000).  
 
1.6 Mitochondrial DNA: replication and transcription  
 
S. cerevisiae cells contain 30-100 copies of mtDNA, which replicates in a rolling circle mode 
starting from at least seven separate origins (rep and ori) containing highly conserved 
sequences (Wallace 1982). Concatenamers are the obligatory intermediates for partitioning of  
mtDNA during cell division, these concatenamers are processed into circular monomers upon 
transmission from mother cells to buds. One hypothesis suggests that in yeast there is a 
selective transmission of a few clones (physically connected) of mtDNA; this means that the 
alleles of the mitochondrial genome quickly segregate during mitosis and within 10-20 cell 
cycles mtDNA becomes genetically homogeneous (homoplasmic) (Ling and Shibata 2004). 
 
Fig. 6 Mechanism of mitochondrial import of nuclear encoded proteins. 
Tom20 is the general receptor for proteins containing presequences, while 
Tom70 recognizes targeting signals present in the mature protein and/or 
those in the presequences. 
www.cgm.cnrs-gif.fr 
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MtDNA maintenance seems to be correlated with the mitochondrial histone Abf2p which 
appears to play an essential role in recombination and copy number determination (Cho et al. 
2001).  
This genome is transcribed by the mitochondrial RNA polymerase (mtRNAP). In S. 
cerevisiae this enzyme is composed of two nuclear encoded proteins, the core Rpo41 and the 
mitochondrial transcription factor Mtf1 (Matsunaga et al. 2004). The transcription is started 
from an highly conserved nonanucleotide (5’-TATAAGTAA [+2] ) promoter sequence. It has 
been found that this sequence plus more than 9 nt of nonconserved sequence 3’ to the 
promoter are essential for mitochondrial specific transcription (Biswas 1999). Transcription 
regulation seems correlated with conformational changes involving a  region of approximately 
300 nt 5’ to the promoter. 
Microarrays and other experiments indicate that in yeast the main determinant for gene 
regulation is the transcription rate; the key factor seems to be the modulation of mRNA 
stability (Garcia-Martinez et al. 2004). Usually transcripts are maturated by cleavage at the 
5’-end and at the 3’-end; 3’ cleavage endonucleases recognize a specific sequence (5’-
AAUAAUAUUCUU-3’) and this cleavage seems to protect mRNA from degradation by 
esonucleases.  
Some mitochondrial genes require intron-specific splicing factors, which are nuclear encoded 
or derivate from some mitochondrial intron sequences. An example of mitochondrial splicing 
is the excision of introns contained in the cytochrome b and subunit I of cytochrome oxidase 
made by the leucyl-tRNA synthetase (NAM2p)(Houman et al. 2000).  
Moreover, the three-dimensional structure of GC-clusters is a maturation signal for some pre-
tRNAs (Francisci et al. 1987). 
 
1.6.1 Mitochondrial tRNAs 
 
The tRNAs are essential molecules for the protein biosynthesis in all living organisms.  
They have specific structural properties required to interact with various proteins like the 
aminoacyl-tRNA-synthetases, the translational initiation and elongation factors, and the 
ribosomal machinery (Helm et al. 2000).  Their sequences have conserved and semi-
conserved information which are essential for interactions and for folding into the “canonical” 
cloverleaf secondary structure (Fig. 7A) and further into a three-dimensional L-shaped 
structure (Fig. 7B).  The “canonical” secondary structure is formed by base-pairing regions 
denominated stems and single strand regions denominated loops. A canonical tRNA contains: 
the acceptor stem, required to bind the aminoacid; the D branch, in which the loop contains a 
diidrouridine; the anticodon branch; the T branch, in which the loop contains the 
pseudouridine (Ψ); and a variable loop. 
The L-shape is due to tertiary interactions and is essentially formed by an anticodon branch 
(consisting of the D-stem and the anticodon-stem) and by an acceptor branch (consisting of 
the acceptor stem and the T-stem). 
The majority of the yeast mitochondrial tRNA genes are localized in a region of 20 Kbp 
between 21S and OXI1 genes. This region contains four promoters, consequently, tRNA 
genes are transcribed as polycistronic pre-tRNAs that require maturation at the 5’ and at the 
3’-end. While the RNase P, a ribonucleoprotein enzyme, removes the 5’-end sequence, the La 
protein binds the 3’ trailer sequence and protects it from exonucleases. The maturation at the 
3’ terminus is still the subject of studies; apparently this processing is due to an endonuclease, 
the RNase Z (Marchfelder et al. 2002).  
tRNAs are substrates of some modifying enzymes. Modified bases vary from 7 to 15 among 
tRNAs, some are tRNA specific while others are conserved, like the diidrouridine in the D-
loop. Some of the modifying enzymes have been identified; for example, Mod5 is a protein 
that modifies the D-loop uridine in diidrouridine (Xing et al. 2002), and N2,N2-  
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Fig. 7 Secondary (A) and tertiary (B) structure of tRNA. 
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dimethylguanine tRNA methyltransferase is able to catalyse the modification of G26 in many 
tRNAs. 
Mitochondrial tRNAs have less modifications compared to their cytosolic counterparts; this 
suggests that this modifications are of higher importance as they are retained by evolution 
(Helm et al. 1999). Moreover, tRNAs modifications are known to stabilize tRNA structure by 
blocking or adding hydrogen bonds. 
The ATP(CTP):tRNA nucleotidyltransferase adds the CCA to the 3’ termini of all the 
mitochondrial tRNAs (Wolfe et al. 1999). 
tRNAs are aminoacylated at their 3’ ends by specific aminoacyl-tRNA synthetases; these 
enzymes have been divided in two classes depending on the catalytic fold, identifiable peptide 
sequence motifs, and distinctive mechanistic features (Francklyn et al. 2002). Aminoacylation 
is a two step reaction in which the amino acid condensates with ATP to form an activated 
amioacyl adenylate intermediate, then the amino acid is transferred to the 3’-terminal ribose 
of the tRNA. The interactions between the synthetases and the cognate tRNA is based on the 
presence of identity elements within the tRNA molecule. In general these elements are 
contained within the acceptor stem and the anticodon region (Stello et al. 1999) 
The mitochondrial genome encodes for all the tRNAs necessary for the organelle protein 
synthesis.  According to the wobble hypothesis the number of required tRNAs is 32 but only 
24 tRNA genes are encoded by the mtDNA; subsequently, mitochondria have a different 
codon usage (Wallace et al. 1982). It has been demonstrated that each tRNA can read two or 
four codons; this capability is correlated with the presence of an uridine in the 5’ position of 
the tRNA anticodon. There are two possible hypotheses to explain this mechanism: the 
uridine in the 5’ position could recognize all the possible four bases or just the first two 
positions of the anticodon are recognized (Martin et. al. 1990). 
 
1.7 Mitochondrial protein synthesis 
 
Translation within the mitochondrial matrix depends upon mRNA specific translational 
activators recognizing targets in the mRNA 5’-unstranslated leaders and mediating mRNA 
interactions with mitochondrial ribosomes (Naithani et al. 2003). 
Mitochondrial ribosomes derived from proteins encoded by nuclear genes (the exception is 
Var1p an essential protein for ribosome biogenesis) and ribosomal RNAs (21S and 16S) 
transcribed from mtDNA. Other proteins are probably involved in the ribosome biogenesis: 
Mtg1p, for example, seems to catalyse a modification of a ribosomal protein that interacts 
with domain V of 21S rRNA or transiently stabilizes an RNA fold (Barrientos et al. 2003). 
Translation consists of three steps: 1) binding of aminoacyl-tRNA, 2) peptide bond formation, 
and 3) translocation of the bound tRNAs and mRNA relative to the ribosome. The 
proofreading and selection of the cognate tRNA at its mRNA depend on codon-anticodon 
interaction and the identification of structural elements of tRNA by the ribosome (Schnitzer 
and Ahsen 1997). 
The initiation involves a set of proteins denominated eukaryotic initiation factors 
(eIFs)(Abbot and Proud 2003). This process starts with the positioning of the ribosomal P-site 
at the start codon, helped by some eIFs factors, and then the initiator methionyl-tRNA 
recognizes the start codon. 
During the elongation the amino acids are added to the growing polypeptide chain. eEF1A  
(EF-Tu) is responsible for delivering the aminoacyl-tRNA to the ribosomal A-site. This 
activity is dependent on GTP and eEF1B (EF-Ts) is the factor promoting the regeneration of 
the eEF1A-GTP. eEF1A forms a ternary complex with tRNA and GTP. In the general model 
of the ternary complex (well conserved in all organisms), the tRNA T-stem contacts the 
domain III of the factor and the acceptor stem contacts the switch regions of domain I. The A- 
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base of the CCA-end binds in a pocket on the surface of domain II and the aminoacyl-ester 
bond is located between domains I and II (Andersen et al. 2003).  
The termination occurs when a stop codon is positioned in the A-site. The eRF complex 
promotes the cleavage of the bond between the peptide and the tRNA, releasing the newly 
synthesized peptide. 
The high fidelity and the speed of the protein synthesis in vivo is achieved through the 
participation of GTP-dependent elongation factors. Over expression of eEF1A in yeast leads 
to decreased translational fidelity (Song et al. 1989). It has been found that eEF1A has 
numerous other functions, e.g. the cytoskeletal remodelling. Moreover, it is an essential 
protein in yeast in which null mutations of this protein are lethal (Cottrelle et al. 1985). 
 
1.8 Human mitochondrial DNA 
 
The human mitochondrial DNA is a circular molecule of 16.569 Kbp (Fig. 8). 
 
 
 
 
 
Fig. 8 Human mitochondrial genome (www.mitomap.org). Genes encoding for different 
subunits of the same oxidative phosphorylation complex are indicated by the same 
colour: ND1-2-3-4-4L-5-6 for complex I (NADH: ubiquinone oxidoreductase) are in 
pink; cytb for  complex III; COI, II, and III for complex IV are in blue; and ATP6 and 8 
for complex V are in yellow. The tRNAs are indicated by their cognate amino acid 
single letter code. rRNAs are indicated in green. The H- and L- strand origins (OH and 
OL) and promoters (PH and PL) are shown. 
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Each cell contains hundreds of mitochondria and thousands of mtDNA molecules. As in 
yeast, the human mtDNA  encodes only for some subunits of the mitochondrial oxidative 
phosphorylation complexes, for the small and large rRNAs and for 22 tRNAs. There is also a 
non coding region denominated D-loop.  
Human mtDNA is a double strand molecule; the two strands can be separated by a density 
gradient and on the basis of their nucleotide composition are termed heavy (H) and light (L) 
strand (or leading- and lagging- respectively). The H-strand encodes for most of the genes. 
Recent studies demonstrated that the mtDNA in mammals replicates by a strand coupled (θ) 
mechanism arising from multiple origins (Bowmaker et al. 2003). This mechanism implies a 
bi-directional initiation zone downstream a powerful replication fork barrier. OH (previously 
designated as an origin for the replication) and D-loop may act as a terminus for the 
replication by forming a structural barrier. 
Sequences without coding functions are absent in animal mtDNA. Transcription probably 
starts at single site for the H- and L-strand and continues symmetrically around the genome. 
Moreover, it has been proposed that tRNA genes, interspersed among the ORFs, can be used 
as recognition sites for processing of the polycistronic transcripts (the punctuation model). 
rRNAs are modified post-transcriptionally by the addition of short adenyl stretches and 
mRNAs are polyadenylated by the mitochondrial poly (A) polymerase (Smeitink et al. 2001). 
 
1.9 Mitochondrial alterations and pathology 
 
The mitochondrial genome is very sensitive to mutations; the mutation rate of mtDNA is 
higher than that of nuclear DNA (Laderman et al. 1996). During the oxidative 
phosphorylation system (OXPHOS) reactions about 1 to 4 % of oxygen uptake is converted to 
oxygen radicals. It has been observed that mtDNA accumulates 16 times more oxidative 
damage than nuclear DNA (Wallace 1992).  
The OXPHOS paradigm is a series of concepts providing an hypothesis to explain 
degenerative diseases. The four basic concepts in the OXPHOS paradigm are: OXPHOS 
produces mitochondrial energy, OXPHOS is the main source of energy for different tissues, 
OXPHOS genetic involves nuclear and mitochondrial genes, OXPHOS declines with age 
(Wallace 1992). 
Mutations in the mtDNA can also cause alterations in the cytoplasmic Ca2+ metabolism in two 
ways: indirectly by reducing the levels of ATP, which is also used by the Ca2+-dependent 
ATPases to pump Ca2+ into intracellular stores or out of the cell; and directly by perturbing 
the mitochondrial membrane potential and therefore the Ca2+ uptake (James and Murphy 
2002). The cytoplasmic Ca2+ concentration (normally around 0.1-1 µM) is also an important 
signal for a number of pathways including hormone regulation. 
Among the metabolic diseases, mitochondrial disorders are the most frequent with an 
estimated incidence of 1 in 10,000 live births (Smeitink et al. 2001). A variety of degenerative 
disorders may be associated with defects in OXPHOS; these defects include base substitutions 
in tRNA and protein coding genes, insertions or deletions in mtDNA, and nuclear mutations 
that cause alteration in the mitochondrial protein synthesis or mtDNA large deletions. It is 
estimated that mtDNA mutations are responsible for 20 % of OXPHOS deficient patients, the 
remaining portion must harbour nuclear gene mutations (Smeitink et al. 2001). On the 
www.mitomap.org web site there is an up-to-date database reporting mtDNA mutations 
correlated with pathologies. 
One example of clinical phenotypes associated with mitochondrial mutations is the  Leber 
ereditary optic neuropathy (LHON). 19 mutations have been associated with this neuropathy, 
5 appear to play a primary role in causing disease. These mutations are transitions in ND6, 
ND4 and cytb genes (Wallace 1995). Other clinical phenotypes associated with mitochondrial 
mutations are: Kearns-Sayre syndrome (KSS), chronic progressive ophthalmoplegia (CPEO),  
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neurogenic muscle weakness ataxia and retinitis pigmentosa (NARP), mitochondrial 
encephalopathy lactic acidosis and stroke like episodes (MELAS), myoclonus epilepsy with 
ragged red fibres (MERRF), diabetes mellitus, Leigh syndrome, Huntington’s disease, and 
even Alzheimer’s and Parkinson’s diseases (Wallace 1992).  
As reported in table 1, nowadays more than 90 different mutations in tRNA genes have been 
correlated with various neuromuscular and neurodegenerative disorders. Although tRNA 
genes represent 10 % of mtDNA, their mutations account for 75 % of mtDNA-related 
diseases. The most frequently observed mutations are A3243G in the tRNALeu(UUR) gene, 
and A8344G in the tRNALys gene, both associated with MELAS syndrome.  
Mitochondrial pathologies are recognized for their typical maternal inheritance, in fact less 
than 0.1 % are contributed by the sperm (Wallace 1992).  
Each cell contains hundreds of mitochondria and thousands of mtDNA molecules; therefore, 
cells can contain a mixture of mutant and normal mtDNA (heteroplasmy). 
 
Table 1 Mutations in mitochondrial tRNA genes correlated with human pathologies  
(www.mitomap.org, 2004). 
 
tRNA Number of 
mutations 
TRNA Number of 
mutations 
tRNA Ala 1 tRNA Lys 12 
tRNA Asn 3 tRNA Met 2 
tRNA Cys 1 tRNA Phe 4 
tRNA Gln 3 tRNA Pro 1 
tRNA Glu 1 tRNA Ser 
(AGY) 
2 
tRNA Gly 5 tRNA Ser 
(UCN) 
8 
tRNA His 3 tRNA Thr 4 
tRNA Ile 12 tRNA Trp 5 
tRNA Leu 
(CUN) 
4 tRNA Tyr 2 
tRNA Leu 
(UUR) 
21 tRNA Val 4 
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The mutant and normal mtDNAs are randomly segregated into the daughter cells during cell 
divisions. Over many cell divisions the proportion of mutant and normal mtDNAs can drift to 
either pure mutant or pure normal (homoplasmy) (Fig. 9). 
As the severity of the pathology is related to the proportion of mutated mtDNA molecules and 
to the energetic threshold of various tissues and organs, the phenotypic effect of mutation 
varies. OXPHOS capacity declines with age; consequently, individuals born with OXPHOS 
mutations have the tendency to reach the energetic limit of an organ and to present disease 
symptoms earlier.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.10 New tools and models to study mitochondrial diseases  
 
Difficulties in the study of mitochondrial pathologies are related to: the different phenotype of 
patients, often due to the genetic background of the mutations (Jacobs and Holt 2000); the 
difficulty in identifying the genetic origin of the dysfunction that may also come from  
 
Mitochondrion with 
mutant  mtDNA 
Mitochondrion with 
normal mtDNA 
Mother cell 
Cell division 
Daughter cells 
Pure mutant cell Pure normal cell 
Fig. 9 During the cellular division process, mitochondria are randomly 
distributed into daughter cells; consequently, their mtDNA can become 
genetically homogeneous. 
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mutations in nuclear genes; and the proportion of mutated molecules, since structural 
alterations can occur in a small fraction of mtDNA population (Laderman et al. 1996). 
To study these pathologies several laboratories developed human cybrids, in which an 
enucleated cell is fused with cytoplasts from a rho° cell. Different cultures of cybrids with 
various proportions of mutated mtDNA molecules are useful to investigate which amount of 
normal molecules are required for the mitochondrial function.  
Cybrids are often used to test the effect of the expression of transfected nuclear genes. In 
some cases it is possible to transfect heterologous genes conserved during the evolution. An 
application of this technique is the analysis of the expression of the algal ATPase 6 gene from 
the Chlamydomonas reinhardtii,  in which it is nuclear encoded, in human cybrids. These 
cells have a pathogenic mutation in the mtDNA-encoded ATPase 6 gene (Ojaimi et al. 2002). 
The tranfected cybrids gained only a minimal increase of cell growth rate due to the moderate 
complementation of function by the algal protein. Endogenous proteins could be engineered 
in order to be expressed in human cells but numerous obstacles need to be overcome to adapt 
this approach to gene therapy. 
Model organisms, such as mice, helped to determine the pathophysiology of mitochondrial 
diseases. Recent studies provide strong evidence that both reduced mitochondrial energy 
output and increased mitochondrial oxidative stress are important factors in the 
physiopathology of mitochondrial diseases (Esposito et al. 1999). Using cre-loxP 
recombination system to disrupt nuclear genes for a transcription factor, Wredenberg et al. 
developed several mouse models for mtDNA disorders. These mice are used to reproduce 
important pathophysiological features found in human patients with mitochondrial myopathy 
in order to finally correlate the mitochondrial mutations to clinical syndromes (Wredenberg et 
al. 2002). 
Gene therapy seems to be almost the only way to cure patients with genetic disorders. More 
than 3,500 patients have been treated over the last 20 years throughout U.S. and Europe 
(Mountain 2000), although there is still no evidence of its efficacy. Gene therapy is going to 
become a reality within the future, taking advantage of the recent improvements in 
“genomics” and “proteomics” (Alesci et al. 2002).  
 
1.10.1 S. cerevisiae as model to study mitochondrial mutations 
 
S. cerevisiae has been successfully used to analyse mitochondrial mutations. Some of its 
advantages are: 
1. the facultative aerobic metabolism; 
2. an homoplasmic content of mtDNA molecules; 
3. a rapid cell cycle;  
4. a well characterized genetic and molecular biology; 
5. the possibility to introduce mitochondrial mutations. 
Fox et al. in 1991 reported a technique to transform yeast mitochondria, denominated 
Biolistic Transformation. This technique uses a device for micro projectiles which is 
necessary to shoot tungsten particles inside yeast cells. These projectiles are prepared with 
exogenous DNA to transform yeast mitochondria. The homologous recombination, which is 
frequent in S. cerevisiae, is one of the main advantage of using this model. 
The biolistic transformation has been successfully used to analyse the effect of the 
introduction in the yeast mitochondrial tRNALeu of three point mutations (Feuermann et al. 
2003). As the human tRNALeu (UUR) sequence (Fig. 10A) and structure are very similar to 
the S. cerevisiae ones, mutations A14G, C26T and T69G, equivalent to the human pathogenic 
A3243G, C3256T and T3291G respectively, have been characterized (Fig. 10A).  
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The defective phenotype of these mutants was strong, in fact these mutants were not able to 
grow on glycerol containing media (respiratory media). At position 69 also the non- 
 
pathogenic  substitutions were introduced and these mutants showed no growth defect on 
respiratory media. This result suggested a good correlation between the pathological 
mutations in humans and the defective phenotypes in yeast.  
In the tRNALeu mutants it has been analysed the suppression by the EF-Tu protein. TUF1 
gene cloned into a multi-copy vector rescued the defective phenotype of LeuA14G, C26T and 
T69G mutants (as an example the C26T mutant suppression is shown in Fig. 10C). 
 
Fig. 10 Panel A shows the comparison between the yeast and human
tRNALeu(UUR) sequences. Panel B shows the mutated positions in the yeast 
mitochondrial tRNALeu. The nucleotides coloured in grey represents the 
conserved bases between yeast and humans. Panel C shows the growth capability 
on respiratory medium of the wt strain, the strain carrying the C3256T equivalent 
mutation and the same mutant transformed with the multi-copy plasmid carrying 
the TUF1 gene. 
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1.11 Aims of the work 
 
An increasing number of pathologies are associated with point mutations in mitochondrial 
tRNA genes but the variable phenotype and the existence of polymorphisms remain a great 
obstacle for the analysis in the human cells.  
Table 1 reports that the majority of the mutations correlated with pathologies are distributed 
in tRNALeu(UUR), tRNAIle and tRNALys genes.  
tRNAs are very conserved molecules because of their crucial role in the protein biosynthesis 
and their interactions with other cellular macromolecules. The analysis of tRNA sequences 
revealed in some cases an high percentage of conserved nucleotides between yeast and 
humans. In relating a list of human pathogenic mutations to the sequence of their yeast 
orthologs, it has been noted that some conserved positions may have the same structural and 
functional importance; therefore these positions were selected to be object of further 
investigations.   
The results obtained with the mitochondrial mutants in the tRNALeu suggested that 
mutations, correlated in humans with neurodegenerative diseases, could be introduced and 
analysed in yeast. Therefore, it was decided to take advantage of the similarity between the 
yeast and the human tRNALys to construct a mutant in position 38 of the yeast mitochondrial 
tRNALys. In humans this position was reported by Houshmand et al. as a novel 
heteroplasmic point mutation consisting in a transition from G to A in position 8328 
(Houshmand et al. 1999). The level of mutated mtDNA varied from 57 % in muscle to 10 % 
in lymphocytes; the muscle tissues had abnormal accumulation of mitochondria and 
cytochrome c oxidase-deficient fibers. This mutation was not found in the muscles or 
lymphocytes of the mother and the daughter of the proband, so this is the first case of a 
sporadic mutation in a patient expressing a mitochondrial encephalomyopathy.  
Prof. M. Zeviani proposed to introduce in yeast the mutation corresponding to the T4290C, 
which corresponds to position 33 in the mitochodrial tRNAIle gene. In humans this mutation 
was reported by Limongelli and colleagues as a homoplasmic mutation present in two sisters 
affected by a mitochondrial disease (Limongelli et al. 2004). One sister was normal until the 
age of 16, and then developed blurred vision, diplopia, headaches, vertigo and weakness. Her 
symptoms increased month after month. A younger sister showed the same disorders but they 
started at an earlier age (6 years old) and she died at the age of 21. For both girls, the brain 
magnetic resonance showed bilateral necrotising encephalomyelopathy,  consistent with 
Leigh Syndrome. Another sister died at the age of 1 year, of respiratory arrest after a minor 
viral infection. Her autopsy reported abnormalities in the mesencephalon. Their mother was 
55 years old and had no neurological symptoms.  
The characterization of two other yeast mutants isolated after random mutagenesis is also 
reported in this thesis. These mutants bear base substitutions in the anticodon stem of the 
tRNA molecule, similarly to those analysed for the biolistic mutants. The comparison of 
phenotypes and the structural analysis of different tRNA mutants may be helpful in 
understanding the importance of each single nucleotide in the functionality of this key 
molecule. 
Moreover, these mutants were used to search for nuclear encoded proteins able to rescue 
mitochondrial defects. The efficiency of the mitochondrial-tRNA synthetases as well as the 
EF-Tu to suppress the defective phenotype was tested. 
Finally, the importance of the nuclear background in which the mitochondrial mutation is 
expressed was investigated. With this aim different experimental approaches were tested, 
changing the nuclear context for each mutant and analysing the expression level of TUF1 
gene in different wild-type and/or rho° strains.  
  
 
 
 
 
 
 
 
 
 
 
 
Materials and methods
Materials and Methods  21 
 
2.1 Strains and conditions 
 
• S. cerevisiae strains: 
 
D273-10B/A1 MATα, met- ura3, ∆leu, KanR, rho+ (Berlani et al. 1980) 
FF1210-6C MAT α, ura 1-2, rho° and rho+ (kindly provided by Prof. M. Bolotin-Fukuhara) 
FF1210-6C MAT α, ura 1-2, ∆leu, CanR, KanR, rho+ (kindly provided by Prof. M. Bolotin-
Fukuhara) 
MCC123 MAT a, ade2, ura3-52, kar1-1, rho° and rho+ (Mulero and Fox 1993) 
MCC123 MAT a, ade2, ura3-52, ∆leu, kar1-1, KanR, rho° and rho+ (kindly provided by Prof. 
M. Bolotin-Fukuhara) 
YGM128 MAT α, ura 1-2, ∆leu, CanR, KanR, rho° and rho+ (Bolotin-Fukuhara et al. 1977) 
TF145 MAT α, ade2-1, ura3-52, mit- oxi1-17 (Fox et al. 1991) 
D273-10B/A1 and FF1210-6C rho° strains have been obtained by Ethidium Bromide 
mutagenesis as described in par. 2.18. 
 
- mitochondrial syn- mutants: 
        x14.25 MAT α, met- (Macino et al. 1979, Berlani et al. 1980) 
        U42C   MAT α, met- (Berlani et al. 1980) 
        Ts9 MATα, ura1-2, ∆leu, KanR (Elelj-Fridhi et al. 1991) 
  C26T MAT a, ade 2, ura 3-52, ura1-2, ∆leu, CanR, KanR (Feuermann et al. 2003) 
        T69C MAT a, ade 2, ura 3-52, ura1-2, ∆leu, CanR, KanR (Feuermann et al. 2003) 
        A14G MAT a, ade 2, ura 3-52, ura1-2, ∆leu, CanR, KanR (Feuermann et al. 2003) 
         
- synthetic rho- (containing only the pJM2 vector with the mutated tRNA gene as unique 
DNA inside their mitochondria) obtained in this work: 
LysG38A a, ade2, ura3-52, kar1-1 
LysG38C a, ade2, ura3-52, kar1-1 
IleT33A a, ade2, ura3-52, kar1-1 
 
- biolistic mutants obtained in this work: 
LysG38A a, ade2, ura3-52, kar1-1 
LysG38C a, ade2, ura3-52, kar1-1 
IleT33A a, ade2, ura3-52, kar1-1 
 
- syn- mutants obtained from nuclear background changes: 
D/x14.25 MATα met-, ura3, ∆leu, KanR 
M/ x14.25 MAT a ade2, ura3-52, ∆leu, KanR, kar1-1 
F/ x14.25 MATα ura 1-2, ∆leu, CanR, KanR 
 
D/U42C MATα met-, ura3, ∆leu, KanR 
M/ U42C MAT a ade2, ura3-52, ∆leu, KanR, kar1-1 
F/ U42C MATα ura 1-2, ∆leu, CanR, KanR 
 
D/ Ts9 MATα met-, ura3, ∆leu, KanR 
M/Ts9 MAT a ade2, ura3-52, ∆leu, KanR, kar1-1 
 
D/LysG38A MATα met-, ura3, ∆leu, KanR 
F/Lys G38A MATα ura 1-2, ∆leu, CanR, KanR 
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• E. coli strain: 
 
  DH5α: end A, hsd R17, sup E44, thi-1, recA1, gyrA, relA1 D (lacZYA-argF), U169 
(F80lacZ ∆M15). 
 
• Yeast growth media: 
 
- Yeast Extract Peptone (YP): 1 % yeast extract and 1 % peptone, supplemented with: 2 % 
glucose (YPD), 2 % galactose, 3 % glycerol, 6 % ethanol, 2 % lactate or  0.4 % galactose 3 
% glycerol. 
 
- Minimum media, 10X Yeast Nitrogen Base (WO) (6.7 g in 100 ml) 2 % glucose, 
supplemented by the required amino acids (50X,1 mg/ml).  
 
• E. coli growth media: 
 
  - LB:  1 % tryptone,  1% NaCl, 0.5% yeast extract, supplemented with ampicillin (1 mg/ml) 
when required. 
 
Solid media contain 1.5 % agar.  
 
2.2 Oligonucleotides  
 
• PCR and sequence oligonucleotides: 
 
5’Thr1+: 5’-CCCTATTTAAGAAGGAGTTT-3’ 
Val-: 5’-GGTGTCTATATATAGGTTTTG-3’ 
Arg2+: 5’-CTAATTATATAGGTTCAAATCC-3’ 
Tyr2-: 5’-GAAGGGAATAGGAATTGAAC-3’ 
Leu+: 5’-GCTATTTTGGTGGAATTGG-3’ 
Arg1-: 5’-ATATTAGAAGTATTATGCTTTAAC-3’ 
 
 
• Oligonucleotides utilized for the site directed mutagenesis: 
 
LysG38A+: 5’-CAGTTGTTTTAAACAACCCATGCTTG-3’ 
Lys G38A-: 5’-CCAAGCATGGGTTGTAAAAGACAACTG-3’ 
LysG38C+: 5’-CAGTTGTTTTAACCAACCCATGCTTG-3’ 
Lys G38C-: 5’-CCAAGCATGGGTTGGAAAAGACAACTG-3’ 
LysG38T+: 5’-CAGTTGTTTTAATCAACCCATGCTTG-3’ 
LysG38T-: 5’-CCAAGCATGGGTTGAAAAAGACAACTG-3’ 
 
IleT33C+: 5’-GGTTAGAATAGTATTCTGATAAGGTACAAATATAGG-3’ 
IleT33C-: 5’-CCTATATTTGTACCTTATCAGAATACTATTCTAACC-3’ 
IleT33A+: 5’-GGTTAGAATAGTATTATGATAAGGTACAAATATAGG-3’ 
IleT33A-: 5’-CCTATATTTGTACCTTATCATAATACTATTCTAACC-3’ 
IleT33G+: 5’-GGTTAGAATAGTATTGTGATAAGGTACAAATATAGG-3’ 
IleT33G-: 5’-CCTATATTTGTACCTTATCACAATACTATTCTAACC-3’ 
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• 5’ –end labelled probes: 
 
THR1:   5’-CCTAAAAACATACATTTTACC-3’ 
ILE:   5’-CCTATATTTGTACCTTATC-3’ 
ARG1:  5’-ATATTAGAAGTATTATGCTTTAAC-3’ 
ASP:   5’-CCTCCATTATGACAAAATGG-3’   
GLN: 5’-GAATCGGTTTGATTCGAACA-3’  
LEU: 5’-GTAATACATCTTAAGAGTATCG-3’ 
VAL: 5’-GGTGTCTATATATAGGTTTTG-3’ 
                               
• TUF1 oligonucleotides: 
 
TUF7+NOT: 5’-TTGCGGCCGCAATTGTAAACTATTTTGTGCT-3’  
TUF4-NOT: 5’-TTGCGGCCGCAAGAAATGAACAGAATATATAG-3’ 
TUF1+: 5’-GTGGTATTACAATTTCTACTG-3’ 
TUF5-: 5’-GATAGCACCATCCATTTG-3’ 
 
 
2.3 Vectors 
 
• TUF1 containing vectors: 
 
-  YEpLAC181TUF1 (Rinaldi et al., 1997) also denominated p181TUF1 
- pFL61TUF1 in which the TUF1 gene, with its own promoter, recleaved from the 
YEpLAC181TUF1, is cloned into EcoRI restriction site of pFL61 vector (Bonneaud et al. 
1991) 
-  pFL61TUF1NOT in which the TUF1 gene is cloned into NotI restriction site of pFL61   
In order to obtain pFL61TUF1 NOT, the TUF1 gene was amplified using TUF7+NOT and TUF4-
NOT oligonucleotides containing the NotI restriction site (Fig. 11). 
 
• Aa-tRNA-synthetase gene containing vectors: 
 
- pCNAM2 (YECpGMC068 Herbert et al. 1988) in which the NAM2 gene is cloned into the 
centromeric vector pFL39 (Bonneaud et al. 1991) under the GAL promoter 
 
- pENAM2 (kindly provided by Prof Claude Jacque) in which the NAM2 gene, with its own 
promoter, is cloned into the multi-copy vector pFL44 (Bonneaud et al. 1991)  
- pMSK1 (kindly provided by Prof. Ivan Tarassov) in which the MSK1 gene, with its own 
promoter, is cloned into pRS416 (Sikorski and Hieter 1989)  
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• Biolistic transformation vectors: 
 
- pTZ18 (Biorad) 
- pKS (pBluescriptII KS, Stratagene) 
- pJM2 derived from pTZ18 and containing the OXI1 gene (Mulero and Fox 1993) 
- Yep352 (Hill et al. 1986) 
- pJMLysG38A in which the 1250 bp mutated tRNALys gene containing fragment is cloned 
into pJM2 vector 
- pJMLysG38C in which the 1250 bp mutated tRNALys gene containing fragment is cloned 
into pJM2 vector 
- pJMIleT33A in which the 800 bp mutated tRNAIle gene containing fragment is cloned into 
pJM2 vector 
 
                            
 
Fig. 11 Restriction map of pFL61 vector. TUF1 gene was cloned 
into NotI restriction site under the PGK1 promoter. 
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2.4 Mitochondrial DNA miniprep  
 
2 ml YP 2 % galactose cultures were transferred to eppendorf tubes, centrifuged and washed 
with 1 ml of distilled water. The pellet was resuspended in 0.2 ml of spheroplasting buffer 
(1.2 M sorbitol, 0.1 M sodium citrate, 60 mM EDTA pH 7, 2 % w/v Zymolyase-20T, 1 % v/v 
β-mercaptoethanol) and incubated for one hour at 37°C. 0.75 ml of lysis buffer (0.5 % SDS, 
100 mM Tris-HCl pH 7.4, 50 mM EDTA pH 8) was then added. After 30 minutes at 65°C, 
0.2 ml of 5 M potassium acetate was added and the mixture was further incubated in ice for 
one hour.  
The tubes were centrifuged for 10 minutes at 13,000 rpm and 0.75 ml of supernatant was 
transferred to a clean new tube, taking care to avoid the surface. The DNA was precipitated 
with 0.75 ml of isopropanol, centrifuged for 10 seconds, resuspended in 0.3 ml of TE (10 mM 
Tris-HCl, 1 mM EDTA) containing RNase (30 µg/mg final) and, incubated for one hour 
37°C. A second precipitation (0.4 M sodium acetate pH 7 plus 3 volumes ethanol) provided 
mitochondrial DNA clean enough to be restricted and cloned. The final resuspension was in 
50 µl of TE pH 8.  
 
2.5 Mitochondrial isolation and purification  
 
200 ml of YP 2 % galactose cultures were centrifuged at 3,000 rpm for 10 minutes and 
washed with water twice.  The pellet was resuspended in a solution containing 0.64 M β-
mercaptoethanol, 0.25 % EDTA pH 7, and incubated for 20 minutes at room temperature. 
0.75 ml of lysis buffer (0.5 % SDS, 100 mM Tris-HCl pH 7.4, 50 mM EDTA pH 8) was then 
added. 
After centrifugation for 10 minutes at 2,500 rpm, the pellet was washed with a solution 
containing 1.1 M sorbitol, 0.05 M phosphate buffer pH 7.5 and resuspended in the same 
solution in which the Zymolyase-20T have been added (1mg per 1-3 g of cells). The 
Zymolyase digestion was incubated at 37°C and followed by O.D. measurements at 600 nm. 
When the O.D. measure was 10 time less than the initial value the digestion was interrupted. 
Protoplasts were centrifuged at 6,000 rpm for 10 minutes and washed with 1.1 M sorbitol. 
Protoplasts were resuspended in lysis buffer containing 0.6 M sorbitol and 10 mM Tris-HCl 
pH 7.4.  
When mitochondria are isolated to prepare RNA extracts, 10 mM vanadylsolphate-ATP, as 
RNase inhibitor, is added. Protoplasts were broken using waring blendor, three times at the 
maximum speed for 30 seconds and then centrifuged at 2,500 rpm 10 minutes, the supernatant 
was centrifuged until cells or debris were completely removed. 
The supernatant was centrifuged at 13,000 rpm for 15 minutes to obtain the mitochondrial 
pellet. 
This pellet was washed three times with lysis buffer. The mitochondrial pellet could be stored 
at –70°C. 
 
2.6 DNA restriction analysis 
 
Restriction enzymes recognize DNA specific sequences and generating fragments of variable 
length, having blunt or protruding ends. Each enzyme requires specific condition of buffer 
and temperature. Digested fragments were checked on 0.7-1 % agarose gel with 1X TBE 
buffer (10X stock solution: 1M Tris base pH 7.4, 0.9 M boric acid, 0.01 M EDTA pH 7). The 
electrophoresis was conducted at 30 mA for the necessary time and the fragments were 
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detected with Ethidium Bromide (1 µl/ml) staining. Lambda phage digested EcoRI/HindIII 
was used as marker.  
 
2.7 Total RNA extraction from purified mitochondria 
 
The mitochondrial pellet was resuspended in 200 µl of 0.3 M sodium acetate pH 5 and 10 mM 
EDTA pH 5. RNAs were extracted by phenol-chloroform pH 5 two times and precipitated 
overnight  using 0.3 M sodium acetate pH 5 and two volumes of 95 % ethanol at –20°C. 
After centrifugation for 15 minutes at 13,000 rpm, the pellet of RNA was washed two times  
with  80 %  ethanol and resuspended in 40 µl  of  10 mM  sodium  acetate  pH 5, 1 mM 
EDTA  pH 4.5. 
RNA concentration was determined by measuring the O.D. at 260 nm. 
tRNA extracted in these conditions are acylated, to obtain deacylated tRNAs the RNA extract 
were subjected to alkaline treatement. 1M Tris base  was added to the samples to the final 
concentration of 0.2 M and the solution was incubated for 90 minutes at 37°C.   
 
2.8 Northern blot  
 
Two glass plates (60x40 cm), typically one slightly different in size from the other, and 
spacers (0.5 mm)  were used to form a watertight seal to put the unpolymerized gel solution. 
The glass plates were washed carefully with 95 % alcohol and the spacers were arranged at 
each side parallel to the two edges. The entire length of the two sides and the bottom of the 
plates were bound with yellow electrical tape. 
To prepare the 6 % polyacrylamide/ 8 M urea gel, 32 g of urea and 10 ml of acrylamide (19:1 
acryl:bisacrylamide) were mixed with 2.2 ml of 3 M sodium acetate  pH  5. The solution was 
warmed to dissolve the urea and then water was added up to the final volume of 66.6 ml. 35 
µl of TEMED (N-N-N-N-tetramethylethylendiamine) and 380 µl of APS (ammonium 
persulfate) were mixed to the gel solution. The gel solution was immediately introduced in the 
space between the two glass plates. The appropriate comb was inserted and the two glass 
plates were laid to minimize distortion of the gel. Acrylamide polymerize in 30 minutes at 
room temperature. The comb and the tape were removed and the two glass plates containing 
the gel were attached to the electrophoresis tank. The upper ad lower reservoirs were filled 
with 0.1 M sodium acetate pH 5. 
8-10 µg of RNAs were mixed with BBF (bromophenol blue and xylene cyanol) dyes and 8 M 
urea with 0.1 M sodium acetate pH 5. The electrophoresis was conducted at 300 V for 20 
hours at 6°C. In these not completely denaturing conditions RNA molecules are separated 
depending on their secondary structure and length. 
After the electrophoresis the two glass plates were separated and the gel was washed two 
times with 5X SSC (20X stock solution: 3 M sodium cloride, 0.3 M sodium citrate). The gel 
was then transferred to nitrocellulose filters (Amersham Hybond-XL) using gel dryer for 1 
hour and 30 minutes at 80°C. 
RNA were fixed using UV rays for 3 minutes on each side. The acrylamide was removed and 
the filters were pre-hybridized with 5X SSC, 5X Denhardt’s solution (100X Denhardt’s: 
BSA2 %, 2 % ficol, 2 % polyvinyl-pyrrolidone) and 0.02 mg/ml of denatured salmon sperma. 
 
2.9 5’-labeling of oligonucleotide primers 
 
The following mixture was prepared on ice: 20-25 picomole of oligonucleotide; 25 µCi of  32P 
γdATP; 5 units/µl of bacteriophage T4 polynucleotide kinase; 2 µl of kinase buffer 10X (500 
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mM Tris pH 9.5, 50 mM Dithiothreitol, 100 mM MgCl2) and water to the final volume of 20 
µl. The solution was incubated at 37°C for 30 minutes. 80µl of STE  (0.1 M NaCl and TE) 
were added to the solution. A sephadex G-50 resin was prepared by centrifugation at 1,600 
rpm for 5 minutes and equilibrated with STE. The solution containing the labeled 
oligonucleotide was applied to the resin and equilibrated with TE. The labeled solution was 
eluted and collected into an eppendorf tube and precipitated using  0.3 M NaAcetate, 3 µl of 5 
mg/ml tRNA carrier and three volume of 95 % ethanol.  
 
2.10 DNA-RNA hybridization 
 
The 5’-end labeled probe was denaturated at 90°C and added to the pre-hybridized filter 
containing the RNAs. The hybridization was conducted for 12 hours at the same temperature 
as the pre-hybridization. 
After hybridisation, the filter was removed from the solution and washed two times with a 
solution containing 2X SSC, 0.1 SDS for 15 minutes at the same temperature. The filter was 
then washed one time with a solution containing 1X SSC, 0.1 SDS for 30 minutes. The filter 
was dried and exposed for 24-48 hours to Biomax MR (Kodak) at –70°C. 
 
2.11 Polymerase Chain Reaction (PCR) 
 
Two oligonucleotide primers were used to amplify specific sequences of DNA using the 
Polymerase Chain Reaction technique (PCR). To conduct the reaction, a mixture of 100 µl 
was prepared as follow: 1 µg of template DNA, 10 µl of 2 mM MgCl2, 0.2 µM of each 
primers, 10 µl of 10X PCR buffer  (10 mM Tris-HCl pH 9, 50 mM KCl, 0.2 ng/ml BSA). 
This mixture was denaturated for 5 minutes at 95°C and placed immediately on dry-ice plus 
ethanol; subsequently, the reaction mixture was placed at the annealing temperature of 56°C. 
2 µl of dNTP (0.2 mM) and 0.5 µl of Taq DNA polymerase 2.5 U were added to the mixture. 
The amplification was carried out starting from 2 minutes at 56°C, continuing for 3 minutes at 
72°C for polymerisation, and again at 94°C for 1 minute for denaturation.  These conditions 
were repeated for 44 cycles. 6 µl of PCR products were checked on agarose gel. 
 
2.12 DNA fragments extraction from agarose gels 
 
The DNA was loaded on 1% low melting agarose gel in TA (0.04 M Tris-acetate). After the 
electrophoresis the band containing the fragment of interest was cut and saved into an 
eppendorf tube. The band was purified using the Amersham kit for gel extractions. The 
sample was eluted using 50% TE.  
The sequence analysis was determinated by Bio Molecular Research Sequencing Service 
(BMR - Padova). 
 
2.13 Preparation of competent E. coli cells 
 
A single colony of E. coli DH5α was inoculated in 2 ml of LB medium and incubated 
overnight at 37°C. 400 µl of this culture were inoculated in 40 ml of LB medium until the 
concentration of 0.2-0.3 OD measured at 550 nm. This culture was incubated on ice for 20 
minutes and then centrifuged at 3,500 rpm for 5 minutes. The pellet was resuspended in 20 ml 
of a sterile ice-cold sterile solution containing 0.05 M CaCl2. After 30 minutes on ice the cells 
were centrifuged and resuspended in 4 ml of the solution above described and incubated for 3-
4 hours. This treatment causes cell wall modifications which increase the permeability of the 
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cells to exogenous DNA. The cell pellet was resuspended in ice-cold sterile glycerol/CaCl2 
solution (glycerol, 15 % (v/v); 50 mM CaCl2) and stored in 300 µl aliquots at  –70°C.  
 
2.14 Transformation of E. coli 
 
40-50 ng of DNA were added to 300 µl of competent E. coli cells. The mixture was incubated 
for 40 minutes on ice. After an heat shock of 3 minutes at 42°C, which allows the exogenous 
DNA to enter the cells, the mixture was incubated for 10 minutes at room temperature. 1 ml 
of LB was added, and the cells were incubated at 37°C for 30-60 minutes.  
200 µl of the mixture containing the transformed cells were plated on LB plus ampicillin, to 
select the transformants.  
 
2.15 Miniprep of E. coli pDNA 
 
1.5 ml of an E. coli overnight culture was centrifuged and resuspended in 100 µl of a solution 
containing 50 mM glucose, 10 mM EDTA, 25 mM Tris-HCl pH 8. After 5 minutes at room 
temperature 200 µl of a fresh solution, containing 0.2 M NaOH, 1% SDS, were added. After 5 
minutes in ice, 150 µl of ice-cold high salt buffer (3M K-Acetate 5 M Acetic Acid) were 
added and the mixture was incubated for 5 minutes at 0°C. After 5 minutes of centrifugation 
at 13,000 rpm, two volumes of 95 % ethanol were added and the mixture was centrifuged for 
10 minutes. The pellet was washed with 70 % ethanol, dried and resuspended in 30 µl of 1X 
TE containing RNase (20 µg/ml).  
2 µl were checked on agarose gel. This preparation of DNA can be stored at –20°C. 
  
2.16 Maxiprep of E. coli pDNA  
 
To obtain large amount of E. coli purified plasmid DNA (pDNA), a colony from transformed 
cells was inoculated in 50 ml of LB ampicillin and incubated overnight at 37°C. The pDNA 
was extracted following the instructions of the Qiagen HiSpeed Plasmid Maxiprep Kit 
manual. The protocol is based on a modified alkaline lysis procedure, followed by binding of 
DNA to Qiagen anion-exchange resin on appropriate low-salt and pH conditions.  
The pDNA was then simply eluted from the resin with TE PH 7.4. 
 
2.17 Transformation of S. cerevisiae using LiCl procedure 
 
Yeast cells were grown in 100 ml of YPD medium to 5x106-2x107 cells/ml (log phase). The 
pellet obtained after centrifugation for 5 minutes at 3,000 rpm was washed with 10 ml of TE 
and resuspended in 1ml of TE containing 0.1 M LiCl. After 60 minutes at 30°C, 100 µl of 
cells were transferred into eppendorf tubes. 5 µl of 10 mg/ml salmon sperm DNA, as a carrier, 
and the appropriate amount of pDNA (2-10 µg) were added to the cells. To one aliquot of 
cells only the carrier DNA was added (control). After an incubation of 30 minutes at 30°C, 1 
ml of 40 % PEG 4000 was added and the mixture was incubated for 60 minutes at 30°C. 
5 minutes at 42°C provided the heat shock necessary to allow the pDNA to enter the cells. 
The cells were then centrifuged for 50 seconds at 3,000 rpm and washed with water twice. 
300 µl of YPD was added to the pellet and the cells were plated on selective media. 
 
2.18 Ethidium Bromide mutagenesis 
 
Yeast cells, grown to stationary phase, were diluted to a concentration of 5x106-2x107 in 2.5 
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ml YPD media. 0.25 ml of  1 M phosphate buffer pH 6.5 and 12  µl of 10 mg/ml ethidium 
bromide were added to the cells and the mixture was incubated overnight. The cells were then 
plated as single colonies on YPD and replica plated on YP 3 % glycerol media to verify the 
absence of growth due to the loss of mitochondrial DNA. 
 
2.19 Small scale yeast total RNA isolation  
 
About  4x108 yeast cells were centrifuged, washed with 1 ml of H2O and transferred into an 
eppendorf tube. The pellet was resuspended in a solution containing: 0.5 M NaCl, 0.2 M 
Tris/HCl pH 7.5, 0.01 M EDTA pH 7.5 and 1 % SDS. 0.4 g of glass beads (0.25-0.3 mm or 
0.45 mm) were added to the solution. 0.2 ml of phenol-chloroform isoamylalcohol 
(25:24:1)(PCI) were added to the solution and vortex at top speed for 2’-2’30’’. After 10 
minutes of centrifugation the aqueous phase was removed and re-extracted in a new tube with 
0.3 ml more PCI. 
The RNA was precipitated overnight  at –20°C using 0.3 M sodium acetate pH 5 and two 
volumes of 95 % ethanol. After centrifugation for 15 minutes at 13,000 rpm, the pellet of 
RNA was washed two times with 80 % ethanol. The pellet was dissolved in sterile water.  
RNA concentration was determined by measuring the O.D. at 260 nm. 
 
2.20 RT-PCR Analysis 
 
Total RNAs were treated with RNase-free DNaseI (Roche Diagnostic GMbH, Mannheim, 
Germany), and their purity and integrity were confirmed by visualisation after separation by 
electrophoresis on agarose gel. 
2 µg of treated RNAs were used to perform a Reverse Transcriptase Reaction, using the 
Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT) by Promega. A 
solution containing the RNAs and 0.5 µg of random hexamers per µg of mRNA sample in a 
total volume of 15 µl of water was incubated at 70°C for 5 minutes and then cooled 
immediately. To this solution were added: 8 µl of 5X reaction buffer (250 mM Tris-HCl pH 
7.4, 375 mM KCl, 15 mM MgCl2, 50 mM DTT), 5 µl of 5 mM dNTP, 0.63 µl of rRNasin 
Ribonuclease inhibitor, 1 µl of M-MLV RT, and water to final volume of 25 µl. The solution 
was incubated for 60 minutes at 37°C followed by 2 minutes at 94°C for denaturation of the 
reverse transcriptase. 2 µl of cDNA were used to perform the Real Time Polymerase Chain 
Reaction (RT-PCR).   
To identify the concentration of cDNA (unknown samples) using the RT-PCR technique, a 
commercial vector containing the gene of interest was carefully quantified and used to prepare 
standard samples of a known quantity (Guenzi 2004). The standard samples were prepared by 
adding to the serial dilutions of DNA (from 1.6 10-2 to 2.56 10-5 ng), 25 µl of the reaction 
mixture, containing 1X iQ SYBR Green Supermix (BioRad), 0.3 mM oligonucleotides, and 
H2O to the final volume of 50 µl. Each standard sample was prepared in duplicate. The 
unknown samples were prepared with 50 ng of cDNA and the same reaction mixture as the 
standard samples; the unknown samples were prepared in triplicate.  
Amplification was carried out in the iCycler apparatus from Biorad, as follow: a denaturation 
step of 5 minutes at 95°C, and 35 cycles of 95°C for 30’’, 54°C for 30’’, and 72°C for 45’’.  
Fluorescence values are recorded during every cycle and represent the amount of product 
amplified to that point in the amplification reaction. The more template present at the 
beginning of the reaction, the fewer number of cycles it takes to reach a point in which the 
fluorescence signal is first recorded as statistically significant above background (Gibson et 
al. 1996). This point is defined as the Ct, and will always occur during the exponential phase 
of amplification. The reporter signals were analysed using the iCycler iQ software (BioRad). 
Materials and Methods  30 
 
These values can be translated into a quantitative result by constructing a standard curve, with 
the standard sample values.  
A melting curve was obtained after completion of the cycles to verify the presence of a single 
amplicon. PCR samples were subjected to a stepwise increase in temperature from 54°C to 
95°C and fluorescence measurements were taken at every temperature increment. The melting 
products cause SYBR green dissociation resulting in decreased fluorescence. If primer-dimer 
or nonspecific products were made during the amplification step, they will generally melt at a 
lower temperature (Tm) than the desired products and in the melting curve two peaks will 
appear. 
 
2.21 Site directed mutagenesis 
 
The site directed mutagenesis was performed following the instruction manual of the 
QuickChange site-directed mutagenesis kit by Stratagene. This kit was used to introduce point 
mutations in specific genes. For this procedure it was utilized 10 ng of double-stranded DNA 
vector containing the insert with the desired wild-type gene and two synthetic mutagenic 
primers complementary to opposite strands of DNA, containing the desired mutation. The 
samples were prepared by adding to the template DNA, 125 ng of each oligonucleotide, 1 µl 
of dNTP mix, 5 µl of reaction buffer, 1 µl of Pfu Turbo polymerase (2.5 U/µl) and water to 
the final volume of 50 µl. The oligonucleotides were extended during PCR cycling by using 
Pfu Turbo DNA polymerase (5’ at 95°C followed by 18 cycles: 1’ 95°C, 1’30’’ at 56°C and 
9’ at 68°C, plus an extension of 7’ at 68°C). The product was treated by 1 µl DpnI. This 
enzyme digested the methylated and hemimethylated parental DNA. The resulted product had 
only the mutation-containing new synthesized DNA. This DNA was used to transform 
competent E. coli DH5α cells according to the transformation protocol reported in par. 2.14. 
 
2.22 Yeast biolistic transformation 
 
This transformation was performed as described by Bonnefoy and Fox 2000. 
Cell preparation:  
The rho° strain to be bombarded was grown for 2-3 days (stationary phase) in 2 % 
galactose/0.1 % glucose. 30 ml of YPD medium were inoculated with 1/50 dilution of the 
stationary culture. One hour before the bombardment the cells were centrifuged   and 
harvested in 1.2 ml of YPD. 100 µl of this suspension were plated on minimal medium 
supplemented with amino acids to provide the appropriated prototrophic selection. 
Preparation of microprojectiles and precipitation of DNA: 
0.7 µm of tungsten particles available from BioRad were sterilized by suspension in 1.5 ml of 
70 % ethanol in an eppendorf tube and incubated at room temperature for 10 minutes. The 
particles were washed with 1.5 ml of sterile water and resuspended in sterile 50 % glycerol. 
In an eppendorf tube 5 µg of plasmid carrying the nuclear marker and a nuclear replication 
origin, and 15 µg of plasmid carrying the mitochondrial DNA of interest were mixed to 100 µl 
tungsten particles. 4 µl of 1 M spermidine free base and 100 µl of ice-cold 2.5 mM CaCl2 
were added and the mixture was incubated for 10 minutes on ice with occasional vortexing. 
The mixture was spin briefly, 15’’ at 13,000 rpm, and the supernatant was removed. The 
particles were resuspended in 200 µl of 100 % ethanol and the procedure was repeated until 
the particles were resuspended easily. The particles were resuspended in 60 µl of ethanol and 
distributed at the center of six macrocarriers placed in their holders, allowing the ethanol to 
evaporate. 
Bombardment: 
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The experiment was done using a 1350 psi rupture disk. The open petri plate carrying the 
lawn of cells was placed at 5 cm from the macrocarrier loaded in its holder into the assembly 
system. The vacuum chamber was evacuated until 27 mmHg  and the particles were shot. 
Any fragments of the macrocarrier disk were removed and the plate was incubated at 28°C for 
4-5 days until colonies appeared. 
Identification of the mitochondrial transformants: 
The plate containing the bombarded cells was replica plated on a lawn of the tester strain 
(TF145) containing a mit- (oxi1-17) mutation on YPD. The cross was incubated at 28°C for 2 
days. This plate was replica plated on YP 3 % glycerol media. In glycerol containing media, 
only cells in which the mit- mutation is complemented by the mitochondrial marker present on 
one of the two shot vectors are able to grow by respiration. From the bombarded plate were 
picked off colonies corresponding to the positions of respiring cells. This test was repeated at 
least three times before pure stable synthetic rho- clones were obtained. 
The synthetic rho- were crossed with a rho+ strain to allow recombination between the 
mutated gene and the wild-type gene present on the mitochondrial genome. If one of the two 
strains carries the karyogamy-defective mutation Kar1-1, the nuclear fusion is reduced while 
the mitochondrial fusion is still efficient. This strategy was used to obtain haploid 
mitochondrial mutants. 
 
2.23 DAPI staining 
 
To visualize the DNA, 1% formaldehyde was added to 100 µl of an exponential culture of 
yeast. After 30 minutes at room temperature the pellet was washed with 100 µl of water. The 
pellet was resuspended in 50 µl of a solution containing 1 µg/ml of 4'-6-Diamidino-2-
phenylindole (DAPI). This dye is known to form fluorescent complexes with natural double-
stranded DNA. After an incubation of 5 minutes the cells were observed using a fluorescence 
microscope at the wavelength of 350 nm. 
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3.1 Construction of new specific mitochondrial tRNA mutants 
 
3.1.1 tRNALys G38A and G38C mutants 
 
The mitochondrial tRNALys gene shows 43 % of conserved bases between yeast and humans. 
Fig. 12 shows the sequence alignment of yeast and human tRNALys genes and the secondary 
structures of the molecules. The human G8328 position (Houshmand et al. 1999) corresponds 
in yeast to position 38. In order to analyse the specific effect of mutations in that position, it 
was decided to introduce not only the G to A (the mutation correlated in humans with the 
Encephalopathy), but also the other two possible substitutions, G to C and G to T. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12 Comparison of yeast and human tRNALys sequences and secondary structures. 
Panel A shows the alignment between the tRNA gene sequences. Plus signs indicate the 
conserved positions between the two genes. The anticodon is underlined. Panel B represents 
the yeast (left) and human (right) cloverleaf structure. In the yeast molecule are indicated the 
mutations studied in this thesis. In the human molecule the arrows indicate the positions 
correlated with pathologies (www.mitomap.org). The underlined positions indicate the 
mutations that have been confirmed as pathological. The red colour indicates the position 
analysed in this work. 
SctRNALys         1 GAGAATATTGTTTAATGGTAAAACAGTTGTCTTTTAAGCAACCCATGCTTGGTTCAACT    C   CAGCTATTCTCA           72 
                                      +         ++      +      +++         +   +      ++    +        ++++++++      +         ++               +                      +    +      ++   +   +   ++                
HstRNALys   8295  CACTGTAAAGC TAAC      TTAG   CATTAACCTTTTAAGTTAAAGATTAA     GAGAACCAACACCTCTTTACACAGTGA  8364  
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From purified mtDNA of wild-type strain FF1210-6C (α, ura1,2),  the TaqI fragment of 1250 
bp  (Fig. 13)  containing  tRNALys  gene was cloned  into ptz18 vector at the AccI restriction 
site. 
 
66231                                   AGTTACCAAA ATTTGAGTTT 
 
66251  GGAGTTTGTT TGTTCGAATC AAACCGATTC AATATTATAA TATATATATT 
 
66301  ATTTATATAT AAATATATAA TTATACTCCT ATTTTTATAT TAATTAATTA 
 
66351  ATAATATATG ATAATATAAA AATTATTGAA TTATTAACTC TTATTAATAA 
 
66401  TAATAATAAT CATAATAATA ATATATATAT ATATAGTATA TATATAAAAG 
 
66451  TTTTATTATA TTATATTATA TTATATATTT ATTTATATAT AATTCTTATT 
 
66501  AATTGAAAAA AGAATAATTA ATAATCTTAT TAAAAAAATA AATACTTTCA 
 
66551  TTTTATTTTA TTTTATTTAA TTTAATTATA ATATATAAAT ATTAAAAAAA 
 
66601  GGATATAAGT TTTTTATAAG ATATAATATA TATATATATT AAATATAAAG 
 
66651  AAGTTAATAT TTATATTTTA ATTATAAAAT GTTAATACTC CTTTGGGGAC 
 
66701  TTATTAATTA AATTATTAAT TAATAATAAT TTATGATTTA TAAATAATAA 
 
66751  ATAAAGGAAT AAGTATCAAT TAATTAATAT ATTATATTTA ATATTTTATA 
 
66801  TTTAATATTT AATATTTAAT ATTTTAAGTT CCGGGGCCCG GCCACGGGAG 
 
66851  CCGGAACCCC GAAAGGAGTA GTATTAATTA TGGATAGTGA GGGTGGATTT 
 
66901  AATCCTTTTG TTATGTTATT AATTAATTAA TTAATTTATA TATATAAAAT 
 
66951  ATTTTAATTA ATTTTTATAT AAATATATAT ATATATATAT ATTAATAATA 
 
67001  GTCCGGCCCG CCCCGTGGGG CGGACCCCAA AGGAGTAATA TATATTATGT 
 
67051  ATAAACAATA GAGAATATTG TTTAATGGTA AAACAGTTGT CTTTTAAGCA 
 
67101  ACCCATGCTT GGTTCAACTC CAGCTATTCT CATAATATTA TATATATATA 
 
67151  TTTCCCTTTC TAAAAATAAT AATAATTATA TATAATAATA ATATAATTAT 
 
67201  ATATATATAT ATTATAATAA TAATAATAAT AATAATAATA AATAATAATA 
 
67251  ATTATTTTTA TTAATAATAT TAATATATTA TAATTATTAA TAAATATTAA 
 
67301  TAAAAATAGC TCTCTTAGCT TAATGGTTAA AGCATAATAC TTCTAATATT 
 
67351  AATATTCCAT GTTCAAATCA TGGAGAGAGT AATTATATTA TATTAATAAT 
 
67401  CCCCCCCCCA TTTTTAATTA AATTAAGAAG TTTAATTTAC TATTTAATAA 
 
67451  TAAATGAAAT AATAATAATA GATATAAGTT AATTGGTAAA CTGGATGTCT 
 
67501  TCCAAACATT GAATGCGA 
 
 
 
 
 
GLN 
LYS 
GLY 
Fig. 13 Region of mitochondrial DNA containing tRNALys gene cloned in the 
pJM2 biolistic vector. The tRNA gene of interest is indicated in red, while other 
tRNA genes are indicated in green. 
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The wild-type sequence of tRNALys was checked by sequencing the insert of this construct 
using the commercial primer M13Reverse.  
This plasmid was mutagenized in vitro following the procedure described in the Quick-
ChangeTM Site-Directed Mutagenesis Kit from Stratagene (Fig. 14). Two mutagenic primers 
complementary to residues from 24 to 52 of tRNALys gene were used to introduce the G38A 
mutation (LysG38A+ and LysG38A-). Similar primers were used to introduce the G38C and 
G38T substitutions (LysG38C+, LysG38C- and LysG38T+, LysG38T-). Only two substitutions 
were obtained and purified plasmid preparations were sequenced to confirm G to A and G to 
C mutations in position 38.  
The biolistic transformation (Fig. 15) was performed as described by Rohou et al. 2001: each 
DNA fragment containing one specific mutation in the tRNALys gene was subcloned into 
pKS vector (pBluescriptII KS, Stratagene) digested EcoRI and SmaI. The inserts were then 
recleaved by EcoRI and BamHI to be ligated into the pJM2 vector (Mulero and Fox, 1993); 
these final vectors contain the OXI1 gene, as mitochondrial marker, and the mutated 
tRNALys fragment, pJMLysG38A or pJMLysG38C. 
For the biolistic transformation cells from the wild-type strain MCC123 (a, ade2, ura3-52, 
kar1-1, rho°)(Mulero and Fox 1993) were prepared according to the method described by Fox 
et al. 1988, and Bonnefoy and Fox 2000. These cells were bombarded randomly by a large 
number of tungsten particles carrying two plasmids, the Yep352 (Hill et al. 1986) with the 
URA3 marker and a nuclear replication of origin, and the pJMLysG38A (or pJMLysG38C). 
The first plasmid allows transformants to grow on selective media (without uracile) for the 
presence of the genetic marker. Further genetic tests were necessary to identify the 
mitochondrial transformants, which received also the second plasmid in the mitochondria. 
The crossover between the URA+ transformants with TF145 (α, ade2-1, ura3-52, mit- oxi1-
17)(Fox et al. 1991) was performed. Both the parental strains are unable to grow on 
respiratory substrates (TF145 because of the presence of the oxi1-17 mutation and MCC123 
rho° because of the absence of the mtDNA). Complementation events between the biolistic 
transformed strain and TF145 result in clones able to grow on respiratory substrates such as 
glycerol, in which the oxi1-17 mutation is complemented by the OXI1 allele carried by 
plasmid pJMLys present in the transformed cells. The corresponding haploid biolistic 
transformants of these positive clones were called “synthetic rho-”, these cells contained only 
the pJMLysG38A (or the pJMLysG38C) plasmid as unique DNA inside their mitochondria.  
To obtain the mitochondrial recombinants, the selected transformants (denominated synthetic 
rho-) were crossed with the wild type YGM128 (α, ura1-2, ∆leu, KanR, CanR)(Bolotin-
Fukuhara et al. 1977). Around 3,500 single colonies were plated on glucose containing media. 
From the observation of the size of the colonies it is possible to obtain information on the 
mitochondrial functionality. To screen for respiratory defects, replica plating onto 3 % 
glycerol media (non fermentable media) at 28°C and 37°C was performed. After the 
screening, 18 colonies of the LysG38A showed a thermo sensitive phenotype on glycerol, 
growing only at 28°C. For LysG38C, 12 colonies were selected for their thermo-sensitive 
defective phenotype, showing slower growth at 28°C and no growth at 37°C. 
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Fig. 15 Biolistic transformation.
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3.1.2 tRNAIle T33A mutant 
 
The primary structure of the mitochondrial tRNAIle gene is extremely conserved among 
mammals (Fig. 16). The S. cerevisiae tRNAIle gene has 66 % of conserved nucleotides with 
the human one. In order to analyse in S. cerevisiae mitochondrial tRNAIle the effect of the 
mutation correlated in humans to the MELAS Syndrome by Prof. Massimo Zeviani 
(Limongelli et al. 2003), the yeast position 33, equivalent to the human position 4290, was 
mutated to introduce the three possible substitutions.  
MtDNA from wild-type strain FF1210-6C was digested by the NsiI restriction enzyme and a 
fragment of 800 bp (Fig. 17) was cloned into ptz18 vector in the PstI site.  
Site-Directed Mutagenesis was performed using for each substitution two couple of 
mutagenic primers complementary to residues from 18 to 54 of tRNAIle gene (IleT33A+, 
IleT33A-, IleT33C+, IleT33C-, IleT33G+ and IleT33G-). Only two substitutions were obtained 
the IleT33C and IleT33A. Purified plasmid DNA from the mutagenesis were prepared and 
sequenced to confirm the point mutations. 
The insert containing the IleT33A mutation was subcloned into pKS vector followed by 
ligation to pJM2 vector, as described for the tRNALys mutants, to construct the pJMIleT33A. 
After the biolistic transformation the synthetic rho- was crossed with YGM128 and 4,500 
single colonies were screened for their mitochondrial functionality. 30 hypothetical 
recombinant colonies were selected for their growth defects on glycerol containing media. 
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SctRNAIle      1     GAAACTATAATTCAA  TTGGTTAGAA  TAGTATTTTGATAAGGTACAAATATAGGTT C    AATCCCTGTTAGTTTC  A   73
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HstRNAIle 4263 AGAAA  TATG    TCTGATAA     AAGAGTTAC      TTTGATAGAGTAAATAA   TAGGAGCTTAAACCCCCTTA  TTTCTA  4331
B 
Fig. 16 Comparison of yeast and human tRNAIle sequences and secondary structures. 
Panel A shows the alignment between the tRNA gene sequences. Plus signs indicate the 
conserved positions between the two genes. The anticodon is underlined. Panel B 
represents the yeast (left) and human (right) cloverleaf structure. In the yeast molecule 
are indicated the mutations studied in this thesis. In the human molecule the arrows 
indicate the positions correlated with pathologies (www.mitomap.org). The underlined 
positions indicate the mutations that have been confirmed as pathological. The red colour 
indicates the position analysed in this work. 
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   69468                    CCG GAACCCCGAA AGGAGAATAA TATAAAATAT 
 
   69501  TATAATTATT TATATATTAA TTATTAATTA TTTATTATTT ATTATATAAA 
 
   69551  AAGTATATAA TTTTATATTT TAATATAGGG TTAATTAATT AATTATTAAT 
 
   69601  TTTTTATAAT AAGATAATAA TATATTAAAA ACTTATTATA AATTTATAAA 
 
   69651  ATAATATTTA TTTACTTTGA TATTATTTTT AATCTTTCAT TAATATATAT 
 
   69701  TTTATTATAA GTAATAATAT AGTTTAATTT AATTAATATA AATAAATTAC 
 
   69751  ATAAGAATAA TATTATAATA ATATTATATA TTATATAAAG AAATAATAAT 
 
   69801  TTATATTTTT ATTTTTTTTA TAAATAATAT AAATATAAAT ATAATGGGGT 
 
   69851  TATAGTTAAA TTTGGTAGAA CGACTGCGTT GCATGCATTT AATATGAGTT 
 
   69901  CAAGTCTCAT TAACTCCAAT AATTATATTA TATAATATAT ATATTAATAA 
 
   69951  ATTATATATA TATATATATA TATAAATATT AAATAAATAT TATATTAATA 
 
   70001  AATAATATAA ATTATCTAAT CGAAGGAGAT ATTTATAATA TAATATAAAT 
 
   70051  ATTTTAATAA ATTAATAAAT ATTATATTAA TAAATAATTA ATAAATATAT 
 
   70101  AAATTATAAT AAATTTTAAT ATTATTATAT AAATTAATTA AATATAATAA 
 
   70151  TTAATGAAAT AGAAACTATA ATTCAATTGG TTAGAATAGT ATTTTGATAA 
 
   70201  GGTACAAATA TAGGTTCAAT CCCTGTTAGT TTCATATTAT ATATCATTAA 
 
   70251  TATATAAAAT ATAAATATAT ATATTATAAT AATAATAATA ATAAATATAA 
 
   70301  ATATAATTAT ATATATATAT ATATATAAAT AAATAATTAT TTAATTTATA 
 
   70351  ATAAATATAT ATAGTTCCCG CGAAGCGGGA ACCCCATAAG GAGTTTTATT 
 
   70401  ATTAATTATA TTTAATAAAT ATTAATTATT AATTTTATAT TTATAAATAA 
 
   70451  ATTTATTACT CCTTCTTAAT TAAGAATAAA AAGGGATGCG GTTCCCATGG 
 
   70501  GGTCCCGCAC TCCTTCGGGG TCCGCCCCCT CCCCTGCGGG AGGGGAGCGG 
 
   70551  ACTATTTTAT TAAAAATATT ATAATTAAAT AATAATATAA ATAATTTATA 
 
       70601  ATATAATAAT ATATAC  
 
 
 
 
 
3.2 Characterization of the mutants 
 
For the LysG38A mutant it was possible to verify the presence of the substitution by 
restriction analysis. In fact this mutation introduces in the tRNALys gene one extra restriction 
site for the DraI enzyme. The mtDNA was extracted from the hypothetical recombinant 
colonies. After the PCR, using Leu+ and Arg1- primers, the recovered 1200 bp fragment 
ALA 
ILE 
Fig. 17 Region of mitochondrial DNA containing tRNAIle gene cloned 
in the pJM2 biolistic vector. The tRNA gene of interest is indicated in 
red, while another tRNA gene is indicated in green. 
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containing the tRNALys gene was checked for the presence of the DraI restriction site (Fig. 
18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LysG38A mutant was analysed for its growth phenotype on different non fermentable media. 
To perform this analysis serial cell dilutions from 10-3 to 10-7 were plated on 3 % glycerol, 2 
% lactate and 6 % ethanol media at 28°C and 37°C (Fig. 19). At the permissive temperature 
of 28°C the mutant showed a slower growth on ethanol, lactate and glycerol containing media 
compared to the wild-type cells, while its growth was absent at 37°C. 
From the preliminary screening for the selection of LysG38C and IleT33A mutants, colonies 
with slower growth on glycerol containing media at 28°C and absence of growth at 37°C were 
isolated. MtDNA was extracted from these cells and amplified by PCR using Leu+-Arg1- 
oligonucleotides for LysG38C and Arg2+-Tyr2- for IleT33A. The sequence of the amplified 
fragments to confirm the presence of the mutations is in progress. 
In order to analyse the presence of tRNALys, Northern blot experiments were performed for 
the LysG38A mutant. Total RNAs from mutant and wild-type purified mitochondria were 
extracted under acidic conditions (pH 5); this condition is able to maintain the acylation status 
of the tRNA molecules.  
The samples (10 µg for each RNA extract) were fractionated in 6 % polyacrylamide-8M urea 
gel (18 hours at 380V). The RNAs were then transferred to nitrocellulose filters and 
hybridised with the 5’-end labelled LYS probe and GLN probe as control (Fig. 20). Fig. 20 
panel A shows that the mutated transcript was present in normal quantity and its migration 
was similar to that of the wild-type transcript. 
 
 
 
 
 
 
 
 
Fig. 18  DraI restriction of the PCR fragments 
amplified from the LysG38A mutant and the wild type. 
800- 
Lys 
G38A WT
1330- 
 500- 
900- 
λ 
E/H
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WT 
28°C 37°C 
Glu 
Lactate 
EtOH 
Gly 
Lys 
G38A 
Fig. 19  Growth comparison of serial cell dilutions of wild type and LysG38A 
mutant at 28°C and 37°C on different carbon sources, 2% glucose, 3% glycerol, 
2% lactate and 6% ethanol.  
A 
B 
WT LysG38A
LYS
GLN 
Fig. 20 Northern blot analysis of mitochondrial transcripts. Total RNAs extracted 
from purified mitochondria of wild type and LysG38A cells, were fractionated on 
polyacrylamide-urea gel. The mitochondrial RNAs were extracted under acidic 
conditions from cells grown at 28°C (A). Hybridization was with the 5’-end 
labelled LYS probe (panel A) or GLN probe as control (panel B). 
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3.3 Characterization of other mutants in the anticodon stem 
 
3.3.1 x14.25 mutant  
 
Berlani et al. have isolated a large number of mitochondrial mutants by MnCl2 mutagenesis 
treatment, showing a defective growth phenotype on glycerol containing media (Berlani et al. 
1980).  
Experiments of complementation using different rho- mutants retaining specific sections of 
the mitochondrial DNA allowed Berlani and his collaborators to locate some of their mutants 
in the tRNA region. 
The mutant denominated x14.25 showed absence of growth on glycerol containing media. 
The complementation experiments located the mutation in a region containing the 
mitochondrial tRNAThr1 gene (Macino et al. 1979). A region of 600 bp containing this gene 
was amplified by PCR using oligonucleotides 5’Thr1+ and Val- and sequenced using the 
5’Thr1+ oligonucleotide. The tRNAThr1 gene sequence showed a C to T transition in position 
40 and an A to T transversion at position 73. Fig. 21 shows the secondary structure of the 
tRNAThr1 in which the mutations are indicated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to verify the presence of tRNAThr1 transcript, total RNAs were extracted from the 
purified mitochondria of this mutant and from the wild type and analysed by Northern blot 
experiments. As previously described, the RNAs were extracted under acidic conditions from 
cells grown at 28°C and 37°C. The filter was hybridised with the 5’-end labelled THR1 probe. 
5’ 
3’ 
C40U
A73U
Fig. 21 tRNAThr1 secondary structure. Red arrows indicate the 
mutated positions in x14.25 mutant.  
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To visualize the transcript it was necessary to load three-fold the usual quantity, i.e. 30 µg, of 
RNAs. Fig. 22 panel A shows that even if the mutated transcript was present in the x14.25 
extracts the amount of this tRNA was much lower in the mutant cells compared to the wild-
type ones. This amount is probably not sufficient to support a normal mitochondrial protein 
synthesis. An aliquot of RNA extracts was then treated with Tris base to hydrolyse the ester 
linkage between the tRNA and the cognate amino acid (deacylated samples). After the 
deacylation treatment it was possible to visualize only a band migrating faster compared to 
the acylated samples indicating that the few molecules of tRNA were acylated. Moreover, 
Fig. 22 shows no difference in the electrophoretic migration between the wild-type and the 
mutant samples. Fig. 22 panel B shows the hybridisation with ASP probe as a control of the 
quality and quantity of the samples; this control demonstrates that the effect of the mutation is 
specific for tRNAThr1.  
As the mitochondrial DNA has two genes for threonine tRNA the frequency of occurrence of 
the Thr1 codon (CTA) was analysed. A Count Codon program available on line at the 
www.kazusa.or.jp web site was used. From this analysis it appears that the codons recognized 
by Thr1 have a frequency of 28.3 (per thousand); this value indicates that these codons are not 
less represented when compared to others.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 U42C mutant  
 
Another mutant isolated by Berlani et al. showed a weakly phenotype on glycerol media, 
growing slowly compared to the wild type at both temperatures of 28°C and 37°C. 
     WT                 X14.25
  28°C         28°C        37°C
 A      D         A      D        A      D 
THR1 
ASP 
A 
 B 
Fig. 22 Northern blot analysis of mitochondrial transcripts. Total RNAs 
extracted from purified mitochondria, isolated from wild type and x14.25 
mutant, were fractionated on polyacrylamide-urea gel. The mitochondrial 
RNAs were extracted under acidic conditions from cells grown at 28°C and 
37°C (A), and then treated to deacylate the tRNA (D). Hybridization was 
with the 5’-end labelled THR1 probe (panel A) and ASP probe as control 
(panel B).  
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The mtDNA region found positive by complementation experiments by Berlani was 
sequenced and the mutation was localized in the mitochondrial tRNAIle gene amplified by 
PCR using Arg2+-Tyr2- oligonucleotides. The sequence revealed a T to C transition at 
position 42 (Fig. 23). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Also for this mutant the presence and the acylation state of the tRNAIle transcript were 
analysed. The RNAs were extracted maintaining the acylated conditions from purified 
mitochondria of cells grown at 28°C and 37°C, and treated for deacylation. Fig. 24 shows that 
the tRNAIle was present and correctly acylated as compared to the wild type. Moreover, the 
electrophoretic mobility of mature U42C tRNAIle was similar to that of wild-type molecule, 
indicating that the mutated tRNAs do not undergo major structural distorsions in these 
conditions. In wild type and in U42C mutant, two bands were present corresponding to the 
acylated and deacylated forms of tRNAIle. The presence of two bands in the acylated 
conditions in both mutant and wild-type transcripts was already observed in other tRNA 
transcript analyses. 
 
 
 
U42C
Fig. 23 tRNAIle secondary structure. Red arrow indicates the 
mutated position in U42C mutant. 
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3.4 Phenotype correction  
 
3.4.1 Suppression by the mitochondrial-tRNA synthetases 
 
It was demonstrated that a multi-copy plasmid bearing the nuclear gene MSD1, encoding for 
the mitochondrial aspartyl-tRNA synthetase, was able to suppress the growth deficient 
phenotype of a tRNAAsp mutant; the mutant has a substitution from C to T in position 62 of 
the T stem (Rinaldi et al. 1997). Similar results were also obtained with a mutant bearing a 
substitution in the acceptor stem of tRNAPhe; this mutant defective phenotype was 
suppressed by its specific synthetase (Francisci et al. 1998). 
On the basis of these experiments, the effect of an over expression of the mitochondrial 
Leucyl-tRNA synthetase, encoded by NAM2, on the biolistic tRNALeu mutants (C26T, T69C 
and A14G) (Feuermann et al. 2003) was investigated. The NAM2 gene was cloned into 
pFL39, a centromeric vector, under the inducible GAL promoter (pCNAM2)(Herbert et al. 
1988), and into pFL44 a multi-copy vector (pENAM2) (kindly provided by Prof. Claude 
Jacque). 
These two vectors were used to transform tRNALeu mutants that showed a drastic phenotype 
on glycerol, as described in the introduction (par. 1.10.1). The transformation was performed 
using the LiCl protocol described in material and methods (par. 2.17). The transformants with 
the centromeric vector were plated on 3 % glycerol and 3 % glycerol/0.4 % galactose media. 
This percentage of galactose was sufficient to induce the GAL promoter but not to support the 
growth of the mutant strains (Fig. 25). LeuT69C and A14G mutants were suppressed by the 
presence of the centromeric vector without the galactose induction; whereas LeuC26T mutant 
was able to grow only when the GAL promoter was induced by the galactose containing 
media or when transformed with the multi-copy plasmid (pENAM2).  
WT U42C 
  28°C                37°C              
A         D          A          D       A 
Fig. 24 Northern blot analysis of mitochondrial transcripts. Total RNAs 
extracted from purified mitochondria, isolated from the wild type and 
IleU42C mutant, were fractionated on polyacrylamide-urea gel. The 
mitochondrial RNAs were extracted under acidic conditions from cells 
grown at 28°C and 37°C (A). Samples were then treated to deacylated the 
tRNA (D). Hybridization was with the 5’-end labelled ILE probe. 
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Previous Northern Blot experiments with LeuC26T mutant showed that the tRNA transcript 
was not detectable because this mutant has a rapid loss of mtDNA (Feuermann et al. 2003). In 
order to analyse the effect of the Leucyl-tRNA synthetases on the transcripts of this mutant, 
mitochondrial total RNAs were extracted from LeuC26T and LeuC26TpNAM2 after an over-
night growth on glucose and after 8, 24 and 48 hours of induction by galactose. The RNAs 
were then fractionated on a polyacrylamide gel and hybridised with LEU probe and VAL 
probe as control. Fig. 26 shows that the tRNALeu in the mutant was detectable only after 24 
hours, and the signal was more evident after 48 hours. Furthermore, the mutated tRNALeu 
migrated more slowly than the wild type. In these electrophoretic conditions molecules are 
separated depending not only on their length but also on their secondary structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 % Gly 
0.4 % Gal 
3 % Gly 
WT Mut pCNAM2 
C26T      T69C    A14G C26T T69C A14G C26T
pENAM2tRNALeu mutants 
Fig. 25 Suppression of tRNALeu mutants C26T, T69C and A14G by NAM2 gene 
cloned into the centromeric vector pCNAM2 (under the Galactose inducible 
promoter) or into the multi-copy pENAM2. 
The transformed strains were plated on glycerol and glycerol/galactose containing 
media. 
                               C26TpCNAM2 
 
WT                0                 8h                24h             48h      
LEU 
VAL 
A 
B 
Fig. 26  Northern blot analysis of tRNALeu C26T mutant transformed with the 
vector pCNAM2. RNAs were extracted from wild-type and mutant strains after 
glucose growth. The transformed mutant was then shifted to galactose containing 
media and RNAs were extracted after 8, 24 and 48 hours. Hybridization was with 
the 5’-end labelled LEU probe (panel A) and VAL probe (panel B) as control. 
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The capability to rescue the tRNA mutant defective phenotype by the mitochondrial-tRNA 
synthetases was tested also with the biolistic mutant LysG38A. The nuclear gene (MSK1) 
coding for the mitochondrial Lysine-tRNA synthetase cloned into a centromeric plasmid 
pRS416 was kindly provided by Prof. I. Tarassov Laboratory.  
The plasmid containing MSK1 gene and the nuclear marker URA3 was used to transform the 
LysG38A mutant. Transformants, selected on minimum media without uracile, were tested 
for their ability to grow on glycerol at 28°C and 37°C. The growth efficiency of transformants 
was compared to that of the wild-type and mutant strains using serial cell dilutions. Fig. 27 
shows that few more copies of MSK1 gene were sufficient not only to restore a wild-type 
phenotype on glycerol containing media at 37°C but also to improve the growth rate 
compared to the wild type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.2 Suppression of mutants by EF-Tu 
 
Previous works (Rinaldi et al. 1997, Francisci et al. 1998, Feuermann et al. 2003) reported 
that the mitochondrial elongation factor (EF-Tu) was able to suppress the defective growth 
phenotype of a large number of tRNA mutants. 
The nuclear encoded TUF1 gene (for the EF-Tu) with its own promoter was recleaved by 
EcoRI from the multi-copy plasmid YEpLAC181TUF1 (here indicated as p181TUF1) 
containing the LEU2 yeast selective marker (Rinaldi et al. 1997). The fragment was 
subcloned into pFL61 multi-copy vector  (containing the URA3 marker)(Bonneaud et 
al.1991). The PCR amplified fragment containing only the TUF1 gene (from p181TUF1) was 
also cloned in the pFL61 vector in the NotI restriction site (pFL61TUF1NOT) (as described in 
WT 
LysG38A 
28°C 37°C 
Gly 
LysG38A 
pMSK1 
Fig. 27  Growth comparison of mutant LysG38A, wild type and LysG38A 
transformed with a vector containing the Lysyl-tRNA synthetase gene (MSK1). 
The three different strains were plated on glycerol containing media and compared 
using  serial cell dilutions. 
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Materials and Methods par. 2.3). This construction permitted the expression of the TUF1 gene 
controlled by the PGK1 promoter, which is the phosphoglycerate kinase strong promoter.  
LysG38A, x14.25, and Ts9 mutants were transformed with three different plasmids 
containing TUF1 and selected on minimum media for the presence of the plasmid. The ability 
of the transformed mutants to grow on glycerol containing media was tested at 28°C and 
37°C.  
Ts9 mutant derived from the mutagenesis of FF1210-6C (Elelj-Fridhi et al. 1991) and was 
previously characterized by Rohou to have a transition from G to A in position 30 in the 
anticodon stem of tRNAGly (Rohou et al. 2001). Its phenotype resulted thermo-sensitive on 
glycerol containing media. 
The data reported in Table 2 show the results of the transformations. It is possible to observe 
that not all the mutants were suppressed by multi-copy plasmids containing the TUF1 gene. 
LysG38A and Ts9 mutants were suppressed by this factor in each of the cloned version. 
x14.25 mutant was not suppressed by any of the three TUF1containing plasmids. U42C 
mutant has a weak phenotype so it was not possible to tested its suppression. 
 
 
 
 
 
 
3.5 Nuclear backgrounds 
 
3.5.1 Different nuclear backgrounds 
 
It was interesting to observe that only the x14.25 defective phenotype was not rescued by the 
TUF1 containing plasmids. As this mutant derived from the mutagenesis of a different wild-
type strain, it was decided to investigate the possibility that the nuclear background influences 
the expression of the mutated mitochondrial gene and the capability to be rescued by nuclear 
encoded proteins.  
Three different wild-type strains were used to change the nuclear background:  
Mutants Localization of the 
mutation 
Gly 
 
 28 °C    37°C 
Transformation Suppression 
 
28°C       37°C 
LysG38A G38A tRNALys     +            - pFLTUF     +             + 
   pFLTUFnot     +             + 
     
x14.25 C40T  tRNAThr1      -            - pFLTUF      -             - 
   pFLTUFnot      -             - 
   p181TUF      -             - 
     
Ts9 G30A tRNAGly     +            - p181TUF     +             + 
   pFLTUF     +             + 
   pFLTUFnot     +             + 
     
U42C T42C tRNAIle +/-        +/- /             / 
Table 2 Analysed mutations of yeast mitochondrial tRNAs. Mutants are indicated by 
their mutation type and position. (+) indicates normal growth, (-) indicates absence of 
growth, and  (+/-) indicates slow growth compared to the wild type. 
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- FF1210-6C, mat α, ∆leu, ura1-2 
- MCC123, mat a, ∆leu, ade2, ura3, Kar1-1 
- D273-10B/A1, mat α, ∆leu, met, ura3 (Berlani et al. 1980)  
These wild-type strains were treated with ethidium bromide to obtain rho° cells. 
The nuclear mutation denominated Kar1-1 offers the advantage of avoiding nuclear fusion 
and therefore recombination between nuclei (Kurihara et al. 2004). Moreover, rho+ cells with 
the ade2 mutation can be distinguished for their red colour, due to the accumulation of a red 
pigment; however, when mitochondria become dysfunctional these cells turn white (Kim et 
al. 2002). 
Fig. 28 represents a cross between a mutant and a wild-type rho° strain, which is in this case 
ade2 and Kar1-1. After 12 hours on YPD medium, the cells were plated as single colonies in 
the same medium. By screening these plates, it is possible to distinguish different colonies for 
their size and colour (Fig. 29): big and white (10 % of diploids); medium and white (haploids 
ade2 unable to breathe or not defective in the adenine biosynthesis); medium and red 
(haploids retaining the ade2 mutation and able to breath); small and white (haploids rho°).  
This strategy was used to change the nuclear context of x14.25, U41C and Ts9 mutants (the 
results are reported in Table 3). The D/x14.25, to indicate its origin from the mutagenesis of 
D273-10B/A1, was crossed with MCC123 wild-type strain (rho°) in order to isolate clones 
with the mutated tRNA and the nuclear background changed from D273-10B/A1 to MCC123 
(denominated M/x14.25). To obtain the M/x14.25, medium red colonies were tested for their 
auxotrophies and growth phenotype on glycerol containing media at 28°C and 37°C. The 
M/x14.25 was then crossed with FF1210-6C (rho°) and medium white colonies were isolated 
and checked to obtain the F/x14.25. Originally unable to grow on glycerol containing media, 
this mutant showed a thermo-sensitive phenotype when the mutation was expressed in an 
MCC123 nuclear background and a wild-type phenotype when the mutation was expressed in 
a FF1210-6C nuclear background. 
Similar experiments were conducted on the F/Ts9 mutant (derived from FF1210-6C), whose 
phenotype resulted thermo-sensitive on glycerol media. The M/Ts9 and D/Ts9 were tested on 
glycerol containing media; both mutants were unable to grow at 37°C or at 28°C.  
The same experiment was repeated for the U42C mutant. Originally isolated from D273-
10B/A1, this mutant showed a weak growth phenotype, growing slower when compared to 
the wild type. The M/U42C and F/U42C were both able to grow as wild type on glycerol 
media. 
LysG38A mutant (mat a, ade2, ura3, Kar1-1), derived from the biolistic transformation of 
MCC123, was crossed with D273-10B/A1 and FF1210-6C wild-type strains (rho°) to obtain 
respectively the D/LysG38A and F/LysG38A mutants. The original phenotype of the mutant 
was temperature sensitive but resulted changed when associated to these different 
backgrounds. The worst phenotype resulted when the mutation was associated with a D273-
10B/A1 nuclear context: this mutant was unable to grow on glycerol at 37°C or at 28°C, so 
that a DAPI staining was performed to confirm the presence of the mitochondrial DNA. After 
the DAPI (4',6-diamidino-2-phenylindole) treatment it is possible to visualize by fluorescence 
microscopy the DNA present inside the cell. The same mutation expressed into an FF1210-6C 
background showed no defective phenotype.  
The experiment on the nuclear context suggested that the mitochondrial protein synthesis 
resulted less damaged when the tRNA mutations were associated to the nuclear context 
FF1210-6C; while the phenotype was more drastic when the tRNA mutations were associated 
to the nuclear context D273-10B/A1. 
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Syn-, mat a strain Mat a, ade2,  Kar 1-1, rho°  
wild type
        Cross on YPD media 
Syn-, ade2, Kar1-1 mutant
rho° 
Syn- mutant 
Diploid
Fig. 28  Example of cross between a syn- mutant and a wild type to obtain the same 
syn- mutation in a new nuclear background. 
mt mutation  associated 
with nuclear context 
(ade2, kar1-1) 
syn- mutant  rho° 
Diploid 
Fig. 29  Growth on glucose medium of colonies obtained by the cross of a syn-
mutant with a wild type (rho°, ade2, kar1-1). It is possible to distinguish different 
colonies for their size and colour: big and white (10 % of diploids); medium and 
white (haploids not defective in the adenine biosynthesis); medium and red (haploids 
retaining the ade2 mutation and able to breath); small and white (haploids rho°).  
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All the mutants described above, in their changed nuclear contexts were transformed with the 
three different plasmids containing TUF1 gene. The results of these suppressions suggested 
that the rescue by the over expression of this factor is linked to the nuclear background in 
which the mutation was expressed (Table 3). From these experiments it is possible to 
conclude that phenotype suppressions not possible in the D273-10B/A1 nuclear context, had 
successful results in the MCC123 context. When the mutations were expressed in the F/ 
context almost no defective phenotype was observed. In the M/Ts9 strain the vector 
pFL61TUF1NOT was not able to rescue the defective phenotype. To test the possible effect of 
these plasmids, the three different wild-type strains were transformed with p181TUF1, 
pFL61TUF1 and pFL61TUF1NOT vectors (data not shown). From these transformations 
resulted that only the MCC123 with pFL61TUF1NOT had a slow growth on glycerol media at 
37°C, indicating that the over expression of TUF1 gene under the PGK1 promoter may have 
toxic effects when associated with the M/ context.    
 
 
 
 
3.5.2 Level of EF-Tu 
 
Table 3 Analysed mutations of yeast mitochondrial tRNAs.  
Mutants were analysed in three different nuclear backgrounds:  
F/ indicates that the mitochondrial mutation was expressed in the FF1210-6C context. 
M/ indicates that the mitochondrial mutation was expressed in the MCC123 context. 
D/ indicates that the mitochondrial mutation was expressed in the D273-10B/A1 context. 
 
Mutants Localization of 
the mutation 
Gly 
 
28 °C     37°C
Transformations Suppression 
 
28°C       37°C 
D/LysG38A G38A tRNALys      -             - pFLTUF      -            - 
   pFLTUFnot      -            - 
M/LysG38A “     +             - pFLTUF      +            + 
   pFLTUFnot      +            + 
F/LysG38A “     +            + /             / 
     
D/x14.25 C40T  tRNAThr1      -             - pFLTUF      -             - 
   pFLTUFnot      -             - 
   p181TUF      -             - 
M/x14.25 “     +             - pFLTUF     +             + 
   pFLTUFnot     +             + 
   p181TUF     +             + 
F/x14.25 “     +            + /             / 
     
D/Ts9 G30A tRNAGly      -             - pFLTUF      -             - 
   pFLTUFnot      -             - 
   p181TUF      -             - 
M/Ts9 “      -             - pFLTUF     +             - 
   pFLTUFnot      -             - 
   p181TUF     +             - 
F/Ts9 “     +             - pFLTUF     +             + 
   pFLTUFnot     +             + 
   p181TUF     +             + 
     
D/U42C T42C tRNAIle +/-        +/- /             / 
M/U42C “ +           + /             / 
F/U42C “ +           + /             / 
Results 52 
 
3.5.2 Level of EF-Tu 
 
A large number of nuclear genes influence mitochondrial activities and in particular our 
experiments suggested that the level of EF-Tu may be crucial for the functionality of the 
tRNA mutated molecules.  
It was decided to determine the absolute quantity of TUF1 gene expressed in different wild-
type samples using a sensitive technique for DNA-RNA analysis such as the Real-time 
Polymerase Chain Reaction (RT-PCR).  
Total RNAs were extracted from FF1210-6C (rho° and rho+), MCC123 (rho+) and D273-
10B/A1 (rho° and rho+) cells. To generate the copy DNA (cDNA), necessary for the 
experiment, 2 µg of RNA extracted from each strain were treated with DNase and used to 
perform a Reverse Transcriptase Reaction (as described in Materials and Methods). 
In order to quantify the concentration of DNA target in these samples it was necessary to 
prepare standard samples of a known quantity and to design a standard curve. The 
YEpLAC181 vector containing TUF1 gene was carefully quantified and used to construct a 
standard curve, using serial dilutions starting from a 1.6 10-2 and ending at 2.56 10-5ng.  
TUF1+ and TUF5- oligonucleotides were chosen to perform the PCR reaction, in fact these 
primers amplified a region of 100 bp. 
The samples were prepared with the SYBR green fluorophore, which is able to bind dsDNA. 
The fluorescence signal emitted by this fluorophore is read at 530 nm from the i-cycler 
apparatus and increases proportionally with the quantity dsDNA amplified. The SYBR green 
fluorophore does not discriminate among different dsDNA molecules so a further control 
using the Melt Curve is required. This curve is able to characterize the PCR product 
eventually revealing the presence of oligonucleotide dimers or PCR artifacts. 
At the end of the reaction the software, provided by Biorad, analysed the fluorescence and 
provided a report with: a curve representing the threshold values (Fig. 30A), a Standard curve 
(Fig. 30B), and a table with all the threshold values (Fig. 30C). 
The following increasing gradient of TUF1 transcript could be extrapolated: rho+ FF1210-6C, 
rho+ D273-10B/A1, rho° D273-10B/A1, rho+ MCC123, rho° FF1210-6C. Two graphics (Fig. 
31) were  drawn  from  the  RT-PCR  data.  
These  results  suggest  that  the amount of TUF1 transcript is not very different among the 
three wild-type strains, but it was interesting to find that the major difference derived from the 
comparison between the rho° and rho+ strains. In particular the rho° FF1210-6C showed a 
level of TUF1 transcript five-fold higher than that of the rho+ strain suggesting the presence of 
a regulative mechanism in this wild type.   
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A PCR Amp/Cycle Graph for SYBR-490 
B Standard Curve Graph for SYBR-490 
C 
Type Identifier Ct Log SQ SQ SQ Ct Ct 
   SQ Mean SD Mean SD 
Standard 1 18.29 -1.796 1.60E-02 1.60E-02 2.11E-10 18.24 6.90E-02 
Standard 1 18.19 -1.796 1.60E-02 1.60E-02 2.11E-10 18.24 6.90E-02 
Standard 2 1,0243056 -3.194 6.40E-04 6.40E-04 1.31E-12 24.02.00 9.52E-02 
Standard 2 24.08.00 -3.194 6.40E-04 6.40E-04 1.31E-12 24.02.00 9.52E-02 
Standard 3 26.60 -3.893 1.28E-04 1.28E-04 1.52E-12 26.51.00 1.35E-01 
Standard 3 26.41.00 -3.893 1.28E-04 1.28E-04 1.52E-12 26.51.00 1.35E-01 
Standard 4 27.53.00 -4.592 2.56E-05 2.56E-05 3.00E-13 27.52.00 1.48E-02 
Standard 4 27.50.00 -4.592 2.56E-05 2.56E-05 3.00E-13 27.52.00 1.48E-02 
Unknown MCC              26.73 -4.144 7.18E-05 6.57E-05 9.11E-06 26.87 2.16E-01 
Unknown MCC              26.77 -4.154 7.01E-05 6.57E-05 9.11E-06 26.87 2.16E-01 
Unknown MCC              27.12.00 -4.258 5.53E-05 6.57E-05 9.11E-06 26.87 2.16E-01 
Unknown FF rho°           24.94 -3.621 2.40E-04 2.31E-04 2.10E-05 25.00.00 1.39E-01 
Unknown FF rho°           24.90 -3.609 2.46E-04 2.31E-04 2.10E-05 25.00.00 1.39E-01 
Unknown FF rho°           25.15.00 -3.685 2.07E-04 2.31E-04 2.10E-05 25.00.00 1.39E-01 
Unknown FF rho+          27.41.00 -4.342 4.55E-05 4.59E-05 5.00E-06 27.40.00 1.62E-01 
Unknown FF rho+          27.24.00 -4.292 5.10E-05 4.59E-05 5.00E-06 27.40.00 1.62E-01 
Unknown FF rho+          27.56.00 -4.387 4.10E-05 4.59E-05 5.00E-06 27.40.00 1.62E-01 
Unknown D273 rho°       26.70 -4.135 7.32E-05 6.78E-05 6.08E-06 26.82 1.36E-01 
Unknown D273 rho°      26.97 -4.213 6.12E-05 6.78E-05 6.08E-06 26.82 1.36E-01 
Unknown D273 rho°       26.79 -4.162 6.88E-05 6.78E-05 6.08E-06 26.82 1.36E-01 
Unknown D273 rho+      27.16.00 -4.269 5.38E-05 5.17E-05 9.15E-06 27.24.00 2.75E-01 
Unknown D273 rho+      27.01.00 -4.225 5.95E-05 5.17E-05 9.15E-06 27.24.00 2.75E-01 
Unknown D273 rho+      27.54.00 -4.381 4.16E-05 5.17E-05 9.15E-06 27.24.00 2.75E-01 
 
Standard Curve Spreadsheet Data for SYBR-490   Units: nanograms  
Fig. 30 Reports from the RT-PCR analysis. 
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Fig. 31 Graphic representation of TUF1 transcript quantification resulted from 
RT-PCR using cDNA from different wild-type strains. Panel A shows the 
comparison among the three different rho+ strains. Panel B shows the comparison 
between rho° and rho+ strains. 
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4.1 Characterization of different mutants in the anticodon stem  
 
In this thesis the effect of point mutations in three mitochondrial tRNA genes has been 
analysed. As no mutants obtained by random mutagenesis reproduce in yeast mutations 
correlated in humans with neurodegenerative pathologies, the biolistic transformation 
was used to introduce specific point mutations.  
From the biolistic transformation and subsequent screening two mutants in position 38 
of the mitochondrial tRNALys were isolated, in particular a transition from G to A 
(correlated in humans with the pathologies by Houshmand) and a transversion from G 
to C. Both these substitutions cause growth defective phenotype on glycerol containing 
media, which indicates problems in the mitochondrial protein synthesis. LysG38A 
mutant showed a temperature sensitive growth phenotype (no growth at 37°C) while the 
other mutant LysG38C showed a slow growth even at 28°C.  
The nucleotide G in position 38 is conserved in almost all the eukaryotic tRNALys, but 
the base-pairing is not conserved. In yeast the G in position 38 binds the U in position 
30 of the anticodon stem; this bond is less strong than the canonical Watson-Crick base-
pair G-C found in the human tRNALys. Consequently, the G to A transition in yeast 
introduces a strong bond in the anticodon stem, while in humans the mutation has the 
opposite effect (the loss of a GC strong base-pair). It would be interesting to introduce a 
C 30 mutation to obtain in yeast the same base-pair present in the human molecule. 
Preliminary screening results on LysG38C mutant suggest that the G to C substitution 
causes in yeast tRNALys a worst phenotype comparing to the LysG38A mutant, 
probably due to the loss of the base-pairing. 
In the mitochondrial tRNAIle only one biolistic mutant, with a T to A transversion in 
position 33, was isolated. This mutant showed a slow growth phenotype only at 28°C on 
glycerol containing media, confirming that the substitution of this nucleotide causes 
effects in yeast as well as in humans. The anticodon loop of this tRNA is highly 
conserved from humans to yeast and it would be interesting to verify the specificity of 
the nucleotide substitution  characterizing the other two mutants, IleT33G and IleT33C, 
not yet obtained. 
The Northern blot experiment with LysG38A mitochondrial RNA extracts showed that 
the signal corresponding to the tRNA transcript was present and had the same 
electrophoretic mobility of the wild-type molecule, indicating no structural defect of the 
molecule of tRNA at least at 28°C; further investigation at 37°C will complete the 
analysis of this mutant transcript. As LysG38A mutant showed growth deficiencies not 
only on glycerol but also on other non fermentable media (lactate and ethanol were 
tested), it is possible to hypothesize that this base of the anticodon stem is important for 
the interactions of this tRNA molecule with its partners during the protein synthesis. 
Other analysed mutants, not related to pathological substitutions in humans but located 
in the anticodon stem, were obtained by random mutagenesis. Even if the mutations 
were located in different tRNA genes, it is possible to speculate on the relevance of the 
mutated positions for the efficient folding of the molecules and for their interactions 
with other molecules.  
x14.25 mutant has two substitutions one localized in position 40 and the other in 
position 73 of the tRNA. This mutant showed absence of growth on glycerol media, 
indicating that the mutations cause strong defect in the mitochondrial protein synthesis. 
The mutation in position 40 causes the loss of a canonical Watson-Crick (C-G) base-
pair probably destabilizing the anticodon stem. The mutation in position 73 of the 
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acceptor stem is not involved in secondary interactions within the molecule, but it is 
known to be an identity element for the aminoacylation reaction in some tRNAs.  
The Northern blot analysis performed with mitochondrial RNAs extracted from x14.25 
revealed low levels of the transcript compared to the wild type. To visualize the mutant 
signals was necessary to over load the samples three-fold more than the usual quantity. 
This experiment revealed no differences in the secondary structures nor in the 
aminoacylation between the tRNAThr1 extracted from the mutant and the wild type. 
Therefore this experiment suggested that positions 40 and 73 are not identity elements 
for this tRNA.  Since this mutant is not able to growth on glycerol media, the low level 
of the tRNAThr1 transcript is probably not sufficient to support the mitochondrial 
protein synthesis. It was observed that mutated tRNAThr1 could not be compensated by 
the tRNAThr2; these two tRNAs recognize different codons. From the analysis of the 
frequency of occurrence resulted that codons recognized by tRNAThr1 are not less 
represented compared to others. 
The results obtained with x14.25 mutant are in agreement with those obtained for the 
Ts9 mutant (Rohou et al. 2000). This mutant has the substitution G30A in the 
tRNAGly; this position is involved in the same secondary interaction G30-C40 as 
x14.25 mutant. This mutant showed a thermo-sensitive phenotype on glycerol media 
and, similarly to x14.25 mutant, showed low level of transcript. It is therefore possible 
to hypothesize that position 40, in agreement with the results observed for Ts9 mutant, 
is important for the steady state level of the transcript probably affecting the stability of 
the tRNA molecule, at least for tRNAThr1 and Gly.  
U42C mutant has a substitution which causes the loss of a canonical Watson-Crick (A-
T) base-pair of the anticodon stem of tRNAIle. Since structure or aminoacylation 
defects were not observed for the mutated tRNAIle by Northern blot analysis, position 
42 seems not to be an identity nucleotide for the yeast mitochondrial tRNAIle. 
Moreover, two bands were present in the mitochondrial extract from the wild-type and 
mutant cells corresponding to the acylated and deacylated sample of tRNAIle. The 
presence of two bands was previously observed for tRNAHis, in fact the cell may 
maintain both the acylated and the deacylated molecules for regulative mechanisms 
(Hinnebusch and Natarajan 2002). Due to the presence of the mutation, U42C mutant 
maintains only two strong base-pairs in the anticodon stem of tRNAIle; therefore, the 
respiratory defect could be the consequence of an alterated structure of the stem. In fact 
from database analyses it has been noted that tRNAs have usually five bonds in the 
anticodon stem; at least four base-pairs are, usually, strong bonds (Watson-Crick base-
pairs). In only two tRNAs (one mitochondrial and one cytoplasmic tRNA) were 
observed three Watson-Crick base-pairs.  
Summarizing the data on the mutants of the anticodon stem reported in this thesis, it is 
possible to observe that: the mutations here investigated do not cause problems in the 
structure and aminoacylation efficiency detectable by Northern blot experiments; the 
bond involving positions 30 and 40 (respectively in Ts9 and x14.25) is important for the 
steady state level of the tRNAs; mutations in LysG38A and U42C mutants, showing no 
defects detectable by Northern blot experiments, probably cause less efficiency in the 
interactions of the tRNA molecules with their partners.  
Further modeling studies, in collaboration with the laboratory of Prof. A. Tramontano, 
permitted the determination of some important structural features of the mitochondrial 
biolistic tRNALeu mutants, in position A14G, C26T and T69C, previously 
characterized (Feuermann et al. 2003). In particular, an adenine in position 14 is 
conserved in almost all the tRNAs and it has a conserved tertiary interaction with the 
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nucleotide in position 8. This interaction may be essential for the correct folding of the 
molecule. Position 26 is involved in a conserved interaction with nucleotide in position 
10. The substitution C26T causes the loss of the hydrogen bond between this position 
and the guanine at position 10 resulting in a destabilization of the secondary structure 
and consequently of the tertiary structure. The nucleotide in position 69 usually has a 
conserved interaction with D loop, but in yeast and humans this region has a different 
pattern; it is, therefore, difficult to determine a general mechanism which may explain 
this mutant phenotype. Recently, in humans, a model has been proposed to explain the 
effects of the A3243G mutation (corresponding to the yeast A14G)(Chomyn et al. 
2000). This mutation alters the tertiary structure of the tRNA so that the molecule is 
deficient for the methylation of the G at nucleotide 3239 and for the modification of the 
uridine at the first position of the anticodon. As a consequence, tRNALeu(UUR) is less 
stable and less efficiently charged by its specific synthetase. The reduced ratio between 
charged and uncharged tRNA affects the association of mRNA to the ribosome. This 
will reduce the protein synthesis and exacerbate the phenotype. 
 
4.2 Suppression by mitochondrial-tRNA synthetases and EF-Tu 
 
It was demonstrated that the nuclear genes MSD1 and MSF1, encoding respectively for 
the mitochondrial Aspartyl-tRNA synthetase and Phenylalanyl-tRNA synthetase, can be 
utilized to suppress the defective phenotype of strains mutated in the mitochondrial 
tRNAAsp and tRNAPhe (Rinaldi et al. 1997, Francisci et al. 1998).  
Mutants in the mitochondrial tRNALeu showed no growth on glycerol containing 
media. In this thesis the defective growth phenotype of these mutants was rescued by 
the over expression of NAM2 gene, encoding for the mitochondrial Leucyl-tRNA 
synthetase (LeuRS). This enzyme has an important role in the mitochondria, in fact it 
has an aminoacyl-tRNA synthetase activity and also a maturase activity, required for the 
correct splicing of  cytochrome b gene. The LeuRS is a class I synthetase  (Ibba and 
Soll 2000), the main characteristic of this class is the capability of the active site to bind 
the acceptor helix of tRNA on the minor groove site. 
In this thesis has been reported that the A14G and T69C mutants were able to grow on 
glycerol when transformed with the centromeric version of the vector containing the 
NAM2 gene (pCNAM), while C26T mutant was suppressed only when the NAM2 gene 
was over expressed by the induction of the GAL promoter in the centromeric vector or 
by the multi-copy plasmid (pENAM2). The positive effect on the tRNA transcript was 
verified by the Northern blot experiment. Previous experiments reported that the C26T 
mutation causes the rapid loss of mtDNA. It was, therefore, neither possible to visualize 
the tRNALeu transcript nor other transcripts in this mutant. The tRNALeu was 
visualized only by Northern blot experiments with RNAs extracted from C26T cells 
transformed with a multi-copy plasmid bearing the TUF1 gene; a similar result was 
obtained, in this thesis, when the RNAs were extracted from the C26T transformed with 
pCNAM2. The tRNALeu transcript was detectable by the Northern blot experiment 
only after 24 hours of galactose induction. The electrophoretic migration of the mutated 
tRNA compared to the wild-type molecule confirmed that the C26T mutation causes 
alteration in the structure of the molecule. The conditional expression of NAM2 gene, 
due to the GAL promoter, offers the possibility to mimic, in some way, the effect of the 
heteroplasmy present in the human cells. By allowing the presence of functional and 
dysfunctional tRNA molecules in the yeast cells, it is, therefore, possible to produce 
intermediate effects. Moreover, these experiments confirm that the functionality of the 
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molecule is rescued not only by the over expression of the EF-Tu (as reported by 
Feuermann et al. 2003) but also by the Leucyl-tRNA synthetase; the transformed 
mutant is also able to retain its mitochondrial DNA. 
Another synthetase was used to verify in vivo the possibility of suppressing the growth 
defect of the LysG38A biolistic mutant. The Lysyl-tRNA synthetase (LysRS) is a class 
II synthetase; this class is distinguished by an N-terminal oligonucleotide binding that 
recognizes anticodon with uridine at the second position. LysG38A mutant, equivalent 
to the human G8328A, was suppressed by the over expression of LysRS, suggesting 
that this position could have, also in yeast, an important role in the interaction of the 
tRNA with the cognate synthetase. Recent in vitro experiments demonstrated that 
G8328A mutation in the human mitochondrial tRNALys leads to a drastic decrease of 
lysylation efficiency (Sissler et al. 2004). In fact Sissler described that the guanine in 
this position is an essential element for a correct aminoacylation of the molecule.  
The specific aminoacyl-tRNA synthetases are not the only proteins which are known to 
rescue mitochondrial tRNA mutant defects. As previously shown, for example, in 
tRNALeu mutants the over expression of TUF1 gene, encoding for EF-Tu, was able to 
rescue the growth defective phenotype on glycerol and to restore a wild-type respiration 
(Feuermann et al. 2003). 
LysG38A mutant, characterized in this work, and Ts9 mutant, characterized by Rohou, 
were suppressed by the TUF1 gene cloned into different multi-copy plasmids. This 
factor may have a positive effect interacting with the mutated molecules and 
rearranging the alterated tRNA structures. This hypothesis could be applied also to the 
synthetases. The studies on the interactions of the tRNA molecules are still in progress; 
recently, Dale and colleagues suggested a principle of “Thermodynamic compensation” 
which explains how these complexes could be stable. This principle is based on the 
combination of strongly binding amino acids with weakly binding tRNA sequences and 
viceversa (Dale et al. 2004). 
Moreover, it has been suggested that some mammalian synthetases, as LysRS, are 
linked to the EF-1 (EF-Tu in yeast) complex for efficient channelling of aminoacyl 
tRNAs to ribosome (Sang Lee et al. 2002). This supramolecular network could play a 
role as an additional control of  the translation.  
The aim of this work is to better understand the pathologies related to mutations in 
tRNA genes and to apply the results obtained in yeast to humans; the high conservation 
of synthetases as well as EF-Tu, suggests the possibility to candidate these proteins to 
further studies on human mutated tRNAs.  In fact as EF-Tu shows 46 % of identity 
between humans and yeast, it could be a good candidate for gene therapy experiments. 
 
4.3 Nuclear Background analyses and suppression by EF-Tu 
 
In humans it has been observed that some mitochondrial disorders are characterized by 
an extremely different penetrance of the disease not only in different individuals but 
also in different tissues and stages of development (Sasarman et al. 2002). 
To investigate the possibility that nuclear background may cause differences in the 
phenotypes of the yeast tRNA mutants, the nuclear context of each mutant described in 
this thesis was changed. To obtain the same mutated mitochondrial genome in a new 
context, a Kar1-1, rho° wild-type strain was crossed with a mitochondrial mutant strain 
(syn- mutants). The results obtained after the crosses revealed that the glycerol growth 
was more defective when the mitochondrial mutations were associated with a D273-
10B/A1 nuclear context compared to the association with an FF1210-6C or an MCC123 
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context. These results suggest the presence of nuclear elements compensating for 
mitochondrial defects.  
To analyse the possibility that the nuclear background may cause differences in the 
suppression capability of the EF-Tu, the three different plasmids containing TUF1 gene 
were used to transform the mutated strains in all three different nuclear backgrounds. 
Surprisingly, it was found that Ts9 and x14.25 mutants, involving the same bond in 
different tRNA molecules, respectively in tRNAGly and Thr1, were not suppressed by 
this factor in the D273-10B/A1 context while they were suppressed when the nuclear 
context was MCC123. These two mutants showed the same molecular defect in the 
Northern Blot experiments and therefore it is possible to hypothesize that some nuclear 
elements may interfere somehow in regulating the mitochondrial transcription levels. 
Another possibility is that nuclear elements may contribute to the stability of the tRNA 
structure by preventing its degradation and allowing its participation to the protein 
synthesis.  
The absolute quantification of TUF1 transcript inside the wild-type strains and their 
isogenic mitochondrial rho° mutants is one attempt to understand its implication in the 
tRNA biogenesis. In this analysis the rho° cells were considered as a model for the syn- 
mutants. The RT-PCR makes it possible to compare relative differences between 
amounts of starting material, whether they be DNA or RNA. The reported results 
showed an increasing gradient of TUF1 transcript (rho+ FF1210-6C, rho+ D273-10B/A1, 
rho° D273-10B/A1, rho+ MCC123, rho° FF1210-6C) derived from the RT-PCR 
analysis. From these data it is possible to draw the following considerations: different 
nuclear contexts have different levels of TUF1 transcript; the rho° have more TUF1 
transcripts compared to their isogenic rho+; it is possible to hypothesize that in the 
FF1210-6C exists a nuclear element able to compensate for the decreased energetic 
level caused by dysfunctional mitochondria, in fact, the FF1210-6C wild-type strain has 
a significant difference in the level of TUF1 transcripts between its rho+ and rho° cells.  
It has been observed that low level of cellular energy, due to mitochondrial mutations in 
tRNA genes, lead to drastic phenotypes when associated with homozygous for 
particular alleles (for example involved in the intracellular regulation of Ca2+)(Johnson 
et al. 2001). Moreover, dysfunctional mitochondria cause in yeast an increase in the 
expression of some nuclear genes, a mechanism called retrograde regulation. An 
example of this pathway was observed in respiratory deficient cells in which the 
absence of TCA cycle activates peroxisomal activity to maintain supplies of 
biosynthetic intermediates (Epstein 2001). 
The preliminary result indicating the difference in the TUF1 transcript level is 
important, in fact, studies on human pathologies correlated to mitochondrial mutations 
suggest that the phenotypes depend not only on the specific tRNA mutations but are 
also regulated by additional genetic and environmental factors. For example, different 
cybrid cell lines were used by Guan et al. to demonstrate that the nuclear genotype 
determines the penetrance of an A to G transition in the mitochondrial 12S rRNA in an 
Arab-Israeli family (Guan et al. 1996).  
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4.4 Conclusions and Perspectives 
 
The results described here contribute to widen the current understanding of the yeast 
system and might provide the basis to derive more general rules, possibly applicable to 
mitochondrial as well as cytoplasmic tRNAs from other species. 
The introduction of mutations in the yeast mitochondrial tRNAs allowed the possibility 
to investigate the pathogenic potential of some human mutations and to search for more 
genes that can either suppress or modify the defective phenotype.  
In the future it will be possible to plan the introduction into yeast of mutations not yet 
obtained in tRNALys and Ile. Moreover, it will be possible to mutagenize position 30 of 
tRNALys to have a condition similar to the human tRNA to demonstrate the specificity 
of the phenotype.  
EF-Tu and aminoacyl-tRNA synthetases could be good candidates to study the effects 
of their expression in human cell lines from different individuals bearing pathogenic 
mutations, but not exhibiting a clear pathology. 
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